Question,Answer,Confidence,Valid
"Will Acadia Pharmaceuticals announce that the Phase 3 ADVANCE-2 trial of pimavanserin for the treatment of negative symptoms of schizophrenia met its primary endpoint by December 31, 2024?",0,1.0,True
"Will the FDA grant full approval to a targeted anti-cancer biologic based on Phase 3 overall survival (OS) data by December 31, 2024?",1,1.0,True
"Will Decibel Therapeutics initiate its Phase 1/2 clinical trial of the gene therapy DB-OTO in pediatric patients by December 31, 2024?",1,1.0,True
"Will Alumis (formerly Esker Therapeutics) announce that ESK-001 met its primary endpoint in its Phase 3 clinical trial for moderate-to-severe plaque psoriasis by December 31, 2025?",0,1.0,True
"Will the European Medicines Agency (EMA) approve Bristol Myers Squibb's Sotyktu (deucravacitinib) for the treatment of moderate-to-severe plaque psoriasis by June 30, 2023?",1,1.0,True
"Will Upstream Bio announce that its Phase 2 VALIANT clinical trial of verekitug (UPB-101) in severe asthma met its primary endpoint by June 30, 2025?",0,1.0,True
"Will scPharmaceuticals receive FDA approval for Furoscix (furosemide injection) for an expanded indication of pediatric heart failure by December 31, 2025?",1,1.0,True
"Will PTC Therapeutics and Novartis announce that the PTC518 Huntington's disease program has met its primary endpoints in the PIVOT-HD Phase 2 trial by December 31, 2025?",1,1.0,True
"Will Intrinsic Medicine initiate its Phase 2 trial for its lead candidate in constipation dominant irritable bowel syndrome (IBS-C) by June 30, 2023?",0,0.9,True
"Will Boehringer Ingelheim announce the initiation of a Phase 3 clinical trial for BI-765128 in diabetic retinopathy by December 31, 2025?",0,1.0,True
"Will Direct Biologics announce that its Phase 3 EXTINGUISH ARDS trial for ExoFlo met its primary endpoint by December 31, 2025?",0,1.0,True
"Will Ionis Pharmaceuticals announce that its Phase 3 CORE trial of olezarsen for severe hypertriglyceridemia met its primary endpoint by June 30, 2025?",0,1.0,True
"Will the FDA approve Takeda and HUTCHMED’s fruquintinib for the treatment of adult patients with metastatic colorectal cancer by December 31, 2023?",1,1.0,True
"Will the FDA approve CRISPR Therapeutics and Vertex Pharmaceuticals' exa-cel (casgevy) for the treatment of sickle cell disease by December 31, 2023?",1,1.0,True
"Will the FDA approve Eli Lilly and Boehringer Ingelheim's Jardiance for the treatment of adults with heart failure independent of left ventricular ejection fraction by February 28, 2022?",1,1.0,True
"Will Novo Nordisk submit a New Drug Application (NDA) to the FDA for CagriSema for the treatment of obesity by December 31, 2025?",1,1.0,True
"Will the FDA approve Bayer's elinzanetant for the treatment of moderate-to-severe vasomotor symptoms associated with menopause by December 31, 2025?",1,1.0,True
"Will the FDA approve Eli Lilly's donanemab for the treatment of early symptomatic Alzheimer's disease by December 31, 2024?",1,1.0,True
"Will Ocular Therapeutix's drug AXPAXLI receive FDA approval for the treatment of wet age-related macular degeneration (wet AMD) by December 31, 2026?",0,0.95,True
"Will the FDA approve a specific genetic test for dihydropyrimidine dehydrogenase (DPD) deficiency as a companion diagnostic for fluorouracil by December 31, 2025?",0,0.9,True
"Will Biogen's Phase 3 trial of lecanemab meet its primary endpoint for slowing cognitive decline in Alzheimer's disease patients by December 31, 2022?",1,1.0,True
"Will the FDA approve Servier's vorasidenib for the treatment of IDH-mutant diffuse glioma by December 31, 2024?",1,1.0,True
"Will Sanofi or Provention Bio announce FDA approval of Tzield (teplizumab) for the prevention of Type 1 diabetes in children under 8 years of age by December 31, 2025?",0,1.0,True
"Will the FDA approve Vertex Pharmaceuticals and CRISPR Therapeutics' exa-cel for sickle cell disease by December 31, 2023?",1,1.0,True
"Will Altesa BioSciences announce that vapendavir met its primary endpoints in its Phase 2b clinical trial for COPD by December 31, 2025?",0,1.0,True
"Will Roche announce the initiation of a Phase 2 clinical trial for its dual GLP-1/GIP receptor agonist CT-388 by December 31, 2024?",1,0.9,True
"Will AstraZeneca's Phase 3 TROPION-Lung01 trial for datopotamab deruxtecan meet its primary endpoint of overall survival in non-small cell lung cancer by December 31, 2024?",0,1.0,True
"Will Eli Lilly's Phase 3 TRAILBLAZER-ALZ 2 trial for donanemab receive a final FDA approval decision for the treatment of early symptomatic Alzheimer's disease by December 31, 2024?",1,1.0,True
"Will the FDA approve Idorsia's aprocitentan for the treatment of resistant hypertension by March 31, 2024?",1,1.0,True
"Will Johnson & Johnson's Phase 3 MARIPOSA trial of amivantamab and lazertinib demonstrate a statistically significant improvement in overall survival (OS) compared to osimertinib by December 31, 2025?",1,1.0,True
"Will the FDA approve Alnylam Pharmaceuticals' vutrisiran (Amvuttra) for the treatment of ATTR amyloidosis with cardiomyopathy by March 31, 2025?",1,1.0,True
"Will the FDA approve Novartis' Cosentyx (secukinumab) for the treatment of hidradenitis suppurativa by December 31, 2023?",1,1.0,True
"Will Novartis submit a regulatory application for remibrutinib to treating chronic spontaneous urticaria (CSU) by December 31, 2024?",1,0.9,True
"Will the European Commission approve Sanofi and Regeneron's Dupixent (dupilumab) for the treatment of adults and adolescents with eosinophilic esophagitis by June 30, 2023?",1,1.0,True
"Will Eli Lilly's donanemab Phase III trial (TRAILBLAZER-ALZ 2) meet its primary endpoint of change in the iADRS scale by June 30, 2023?",1,1.0,True
"Will Ocular Therapeutix's experimental eye drug AXPAXLI meet its primary endpoint in the late-stage trial for wet AMD by December 31, 2025?",1,1.0,True
"Will Adicet Bio launch a pivotal Phase 2 clinical trial for ADI-001 by June 30, 2023?",0,0.9,True
"Will Boston Scientific's mCRM (modular cardiac rhythm management) system receive FDA approval for clinical use by December 31, 2024?",0,0.9,True
"Will Viatris and Kindeva Drug Delivery launch their generic version of Symbicort (Breyna) in the United States by December 31, 2022?",0,1.0,True
"Will Aelis Farma announce results from its Phase 1/2 clinical trial of AEF0217 in patients with Down syndrome by December 31, 2023?",0,1.0,True
"Will Day One Biopharmaceuticals submit a New Drug Application (NDA) to the FDA for tovorafenib by June 30, 2023?",1,1.0,True
"Will the FDA expand the approved indication of Sarepta Therapeutics' Elevidys to include Duchenne muscular dystrophy patients of all ages by January 1, 2025?",0,1.0,True
"Will Novo Nordisk receive FDA approval for a new indication for Wegovy (semaglutide) based on clinical trial results by December 31, 2024?",1,1.0,True
"Will the FDA approve Takeda and Otsuka's centanafadine for the treatment of ADHD by June 30, 2025?",0,1.0,True
"Will Sandoz's Hyrimoz (adalimumab-adaz) biosimilar achieve a cumulative US market share of at least 10% in the adalimumab market by December 31, 2024?",1,1.0,True
"Will Kairos Pharma complete its Phase 1 clinical trial of KROS-201 for the treatment of glioblastoma by December 31, 2025?",0,1.0,True
"Will BioMarin Pharmaceuticals' gene therapy Roctavian (valoctocogene roxaparvovec) receive FDA approval for the treatment of hemophilia A by December 31, 2023?",1,1.0,True
"Will the U.S. Supreme Court issue a ruling that maintains the FDA's 2016 and 2021 expanded access changes for mifepristone by July 1, 2024?",1,1.0,True
"Will BioMarin's gene therapy Roctavian receive expanded FDA label approval for a pediatric population by December 31, 2025?",0,1.0,True
"Will Roche's GLP-1 agonist CT-388 meet its primary endpoints in the Phase 2 clinical trial for obesity by December 31, 2024?",0,1.0,True
"Will the FDA issue a final administrative order to remove oral phenylephrine from the list of generally recognized as safe and effective (GRASE) OTC active ingredients by December 31, 2025?",0,1.0,True
"Will the FDA approve Vertex Pharmaceuticals' vanzacaftor triple combination regimen (vanza triple) for the treatment of cystic fibrosis by March 31, 2025?",1,1.0,True
"Will the FDA grant approval for Autolus Therapeutics' obecabtagene autoleucel (obex-cel) for the treatment of adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia by December 31, 2024?",1,1.0,True
"Will the Phase 2 trial on LINAC-Based Stereotactic Arrhythmia Radioablation for Paroxysmal Atrial Fibrillation (led by Fabiana Gregucci et al.) publish its final primary endpoint results by December 31, 2026?",1,1.0,True
"Will Thermedical's pivotal clinical trial of the SERF thermal ablation system with the Durablate Catheter for ventricular tachycardia reach its primary completion date by December 31, 2025?",0,1.0,True
"Will Eli Lilly's lebrikizumab receive FDA approval for the treatment of moderate-to-severe atopic dermatitis by December 31, 2024?",1,1.0,True
"Will Viking Therapeutics' Phase 3 trial for VK2735 meet its primary endpoint of significant weight loss relative to placebo by December 31, 2025?",0,1.0,True
"Will the Phase 3 LITESPARK-005 trial evaluating Welireg (belzutifan) against everolimus in advanced clear-cell renal cell carcinoma demonstrate a statistically significant improvement in overall survival (OS) by December 31, 2024?",0,1.0,True
"Will the 5th U.S. Circuit Court of Appeals uphold the FDA's removal of the in-person dispensing requirement for mifepristone following its hearing on May 17, 2023?",0,1.0,True
"Will the FDA approve Novo Nordisk's once-weekly insulin icodec for the treatment of diabetes by December 31, 2024?",0,1.0,True
"Will the FDA approve Merck's Keytruda (pembrolizumab) in combination with pemetrexed and platinum chemotherapy for the first-line treatment of unresectable advanced pleural mesothelioma by December 31, 2024?",1,1.0,True
"Will Sanofi's Tzield (teplizumab-mzwv) receive FDA approval for the treatment of newly diagnosed Stage 3 Type 1 Diabetes in children and adolescents by July 31, 2024?",0,1.0,True
"Will AstraZeneca's datopotamab deruxtecan (Dato-DXd) receive FDA approval for the treatment of advanced or metastatic non-small cell lung cancer by December 31, 2024?",0,1.0,True
"Will Ironwood Pharmaceuticals submit a New Drug Application (NDA) to the FDA for apraglutide by December 31, 2024?",0,1.0,True
"Will AstraZeneca's Phase 3 trial (TROPION-Lung01) for datopotamab deruxtecan demonstrate statistically significant improvement in overall survival for patients with non-small cell lung cancer by December 31, 2024?",0,1.0,True
"Will Summit Therapeutics receive FDA approval for ivonescimab as a first-line treatment for PD-L1-positive non-small cell lung cancer by December 31, 2025?",0,1.0,True
"Will the FDA approve bluebird bio's gene therapy elivaldogene autotemcel (eli-cel) for cerebral adrenoleukodystrophy by September 30, 2022?",1,1.0,True
"Will Merck & Co.'s Phase 3 KEYNOTE-A18 trial for locally advanced cervical cancer receive FDA approval for its supplemental Biologics License Application (sBLA) by December 31, 2024?",1,1.0,True
"Will Idorsia's insomnia drug daridorexant receive market approval from the European Medicines Agency (EMA) by June 30, 2022?",1,1.0,True
"Will Otsuka and Click Therapeutics' Rejoyn app be available for download on the iOS and Android app stores by December 31, 2024?",1,1.0,True
"Will the FDA approve Cellectar Biosciences' Iopofosine I 131 for the treatment of relapsed/refractory Waldenstrom's macroglobulinemia by December 31, 2025?",0,1.0,True
"Will Mirum Pharmaceuticals report that the Phase 3 trial of Chenodal for cerebrotendinous xanthomatosis met its primary endpoints by December 31, 2024?",1,1.0,True
"Will the European Medicines Agency (EMA) grant marketing authorization for elacestrant (ORSERDU) for the treatment of patients with ESR1-mutated ER+/HER2- metastatic breast cancer by December 31, 2023?",1,1.0,True
"Will Acelyrin's Phase 2b/3 trial of izokibep for psoriatic arthritis meet its primary endpoints by March 31, 2024?",1,1.0,True
"Will Eli Lilly receive FDA approval for an expanded indication of Emgality (galcanezumab) to treat pediatric migraine by December 31, 2024?",0,1.0,True
"Will Karuna Therapeutics report top-line data from the EMERGENT-2 Phase 3 trial of KarXT by August 31, 2022?",1,1.0,True
"Will Abivax begin patient enrollment in its Phase 3 clinical program of ABX464 for moderate-to-severe ulcerative colitis by June 30, 2022?",0,1.0,True
"Will the FDA grant final approval to Karuna Therapeutics' KarXT (xanomeline-trospium) for the treatment of schizophrenia by September 26, 2024?",1,1.0,True
"Will Rejuvenate Biomed initiate a Phase 2 clinical trial for its lead candidate RJx-01 to evaluate its effect on sarcopenia by December 31, 2024?",0,1.0,True
"Will PDS Biotechnology initiate the Phase 3 VERSATILE-003 trial for PDS0101 in recurrent or metastatic HPV16-positive head and neck squamous cell carcinoma by December 31, 2024?",0,1.0,True
"Will AbbVie's Rinvoq (upadacitinib) receive FDA approval for the treatment of alopecia areata by December 31, 2025?",0,0.9,True
"Will Fosun Pharma present updated clinical data for LegoChem Biosciences' LCB14 (FS-1502) at the San Antonio Breast Cancer Symposium by December 31, 2022?",1,0.9,True
"Will the FDA approve Mallinckrodt's terlipressin for the treatment of hepatorenal syndrome (HRS) by December 31, 2022?",1,1.0,True
"Will AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan (Dato-DXd) receive FDA approval for the treatment of adult patients with unresectable or metastatic nonsquamous non-small cell lung cancer by December 31, 2024?",0,0.9,True
"Will the FDA approve Bristol Myers Squibb's supplemental New Drug Application (sNDA) for KRAZATI (adagrasib) in combination with cetuximab for KRAS G12C-mutated colorectal cancer by December 31, 2024?",1,1.0,True
"Will the European Commission grant marketing authorization for Takeda’s HYQVIA as a maintenance therapy for adults with chronic inflammatory demyelinating polyneuropathy (CIDP) by December 31, 2024?",1,1.0,True
"Will the FDA approve Eli Lilly's Alzheimer's drug donanemab by December 31, 2024?",1,1.0,True
"Will AstraZeneca's durvalumab (Imfinzi) maintain its status as the recommended standard of care for unresectable stage III NSCLC in updated NCCN clinical practice guidelines through December 31, 2025?",1,0.9,True
"Will the FDA approve GSK's gepotidacin for the treatment of uncomplicated urogenital gonorrhoea by June 30, 2025?",0,1.0,True
"Will the FDA approve Regeneron and Sanofi's Dupixent (dupilumab) as a treatment for eosinophilic esophagitis by May 31, 2022?",1,1.0,True
"Will the FDA expand the approval of Gilead Sciences' remdesivir (Veklury) to include treatment for children under 12 years of age by April 30, 2022?",1,1.0,True
"Will Transgene complete enrollment for its Phase 2 study of TG4050 for head and neck cancer by December 31, 2027?",1,1.0,True
"Will Idorsia Pharmaceuticals' aprocitentan receive marketing authorization from the European Medicines Agency (EMA) by December 31, 2024?",1,1.0,True
"Will the FDA approve batoclimab for the treatment of generalized myasthenia gravis (gMG) by December 31, 2025?",0,1.0,True
"Will WW International, Inc. announce results from a new clinical trial evaluating its diabetes-tailored program in a peer-reviewed medical journal by December 31, 2024?",1,0.9,True
"Will the U.S. Supreme Court issue a ruling that restricts the current FDA-approved mail-order availability of Danco Laboratories' mifepristone by July 31, 2024?",0,1.0,True
"Will Novo Nordisk's CagriSema Phase 3 REDEFINE 1 trial meet its primary endpoints for weight loss by December 31, 2024?",1,1.0,True
"Will Gilead Sciences' PURPOSE 2 Phase 3 clinical trial of lenacapavir for HIV prevention meet its primary endpoint by June 30, 2025?",1,1.0,True
"Will Alnylam Pharmaceuticals' HELIOS-B Phase 3 trial of vutrisiran meet its primary composite endpoint for the treatment of ATTR amyloidosis with cardiomyopathy by December 31, 2024?",1,1.0,True
"Will the FDA approve Bayer's elinzanetant for the treatment of moderate to severe hot flashes associated with menopause by December 31, 2025?",0,1.0,True
"Will Alumis launch a Phase 3 clinical trial for ESK-001 in plaque psoriasis by December 31, 2024?",1,1.0,True
"Will Biogen's Phase 3 ATLAS trial of QALSODY (tofersen) in presymptomatic SOD1-ALS achieve its primary completion by December 31, 2026?",0,0.9,True
"Will the Personalized Parkinson Project (NCT033648) complete its 3-year longitudinal follow-up period for all 520 participants by December 31, 2025?",0,0.9,True
"Will Roche's Phase 3 SKYSCRAPER-01 trial of tiragolumab plus atezolizumab meet its primary endpoint of overall survival by December 31, 2024?",0,1.0,True
"Will the FDA approve Pfizer's Abrysvo vaccine for use in pregnant individuals to protect infants from RSV by September 30, 2023?",1,1.0,True
"Will Cidara Therapeutics announce that their CD388 Phase 2a trial for the prevention of influenza A reached its primary efficacy endpoint by June 30, 2025?",1,1.0,True
"Will Eli Lilly's triple agonist (retatrutide) successfully meet its primary endpoint for weight loss in its Phase 3 trial by December 31, 2025?",1,1.0,True
"Will the U.S. Supreme Court issue a ruling in FDA v. Alliance for Hippocratic Medicine that restricts the current distribution rules for the drug mifepristone by June 30, 2024?",0,1.0,True
"Will Radella Pharmaceuticals initiate its Phase Ib clinical trial for MD-18 by December 31, 2024?",1,1.0,True
"Will Amgen's rocatinlimab (AMG 451) Phase 3 trial for moderate-to-severe atopic dermatitis meet its primary endpoint of clinical response by December 31, 2024?",1,1.0,True
"Will the FDA approve Biogen and Sage Therapeutics' zuranolone for the treatment of major depressive disorder by August 5, 2023?",0,1.0,True
"Will Metro International Biotech's MIB-626 clinical trial for Alzheimer's disease (NCT05040321) be completed by December 31, 2024?",0,1.0,True
"Will Arcellx and Kite's Phase 2 iMMagine-1 trial for CART-ddBCM in multiple myeloma meet its primary endpoint by December 31, 2025?",1,1.0,True
"Will SpringWorks Therapeutics submit its New Drug Application (NDA) to the FDA for mirdametinib for the treatment of NF1-PN by June 30, 2024?",1,1.0,True
"Will Florida's Department of Health successfully import its first shipment of prescription drugs from Canada under the FDA-approved program by December 31, 2024?",0,1.0,True
"Will Ionis Pharmaceuticals submit a New Drug Application (NDA) to the FDA for olezarsen for the treatment of familial chylomicronaemia by June 30, 2024?",1,1.0,True
"Will the Phase 3 CLEAR Outcomes trial demonstrate that bempedoic acid significantly reduces the risk of major adverse cardiovascular events (MACE-4) compared to placebo by December 31, 2023?",1,1.0,True
"Will Alentis Therapeutics report data from a Phase 2 clinical trial of ALE.F02 in organ fibrosis by December 31, 2024?",0,1.0,True
"Will Eli Lilly's Zepbound (tirzepatide) receive FDA approval for the treatment of obstructive sleep apnea by December 31, 2025?",1,1.0,True
"Will the FDA approve Ocular Therapeutix's DEXTENZA for the treatment of pediatric ocular inflammation following ophthalmic surgery by December 31, 2024?",1,1.0,True
"Will the Phase 2 trial of dasatinib, blinatumomab, and prednisone for older patients with Ph+ ALL (NCT02143414) report a final 5-year overall survival rate of 75% or higher by December 31, 2026?",0,1.0,True
"Will Autolus Therapeutics submit a Biologics License Application (BLA) to the FDA for obe-cel by December 31, 2023?",1,1.0,True
"Following the registration lapse, will the US FDA officially withdraw the New Drug Application (NDA) for Bufferin (aspirin/antacid) by December 31, 2023?",1,1.0,True
Did the SMARTrial (NCT03488641) meet its primary endpoint of providing drug response profiling reports within 7 days for at least 90% of study participants?,1,1.0,True
"Will Vertex Pharmaceuticals release clinical data from its Phase 1 trial of VX-264 for type 1 diabetes by December 31, 2025?",1,1.0,True
"Will Nanoscope Therapeutics announce topline results from its Phase 2 trial of MCO-010 in Stargardt disease by June 30, 2023?",0,1.0,True
"Will Renibus Therapeutics initiate its Phase 3 registrational study of RBT-1 by March 31, 2023?",0,1.0,True
"Will any of the four FDA-ordered breast implant post-market surveillance studies listed as 'ongoing' on October 1, 2024, reach 'completed' status by December 31, 2025?",0,0.9,True
"Will AbbVie submit a New Drug Application (NDA) for tavapadon to the US Food and Drug Administration by December 31, 2025?",1,1.0,True
"Will Roivant Sciences' subsidiary Immunovant report positive topline Phase 3 data for batoclimab in generalized myasthenia gravis (gMG) by December 31, 2024?",0,1.0,True
"Will Agomab Therapeutics' Phase 2 trial of AGMB-129 for fibrostenosing Crohn's disease meet its primary endpoints by December 31, 2025?",1,1.0,True
"Will the FDA approve Novocure's TTFields therapy for patients with brain metastases from non-small cell lung cancer by December 31, 2025?",0,1.0,True
"Will GenBioPro's generic mifepristone remain FDA-approved for use in the United States through December 31, 2024?",1,1.0,True
"Will Nimbus Therapeutics release results from its Phase 1/2 trial of NDI-101150 in patients with solid tumors by December 31, 2024?",1,1.0,True
"Will the FDA approve Aldeyra Therapeutics' reproxalap for the treatment of dry eye disease by November 30, 2023?",0,1.0,True
"Will the FDA approve Mapi Pharma and Viatris's GA Depot (glatiramer acetate 40 mg) for the treatment of relapsing forms of multiple sclerosis by December 31, 2025?",0,1.0,True
"Will the FDA approve Checkpoint Therapeutics' cosibelimab for the treatment of advanced cutaneous squamous cell carcinoma by December 31, 2024?",1,1.0,True
"Will Eli Lilly's Alzheimer's drug donanemab receive marketing authorization from the European Medicines Agency (EMA) by June 30, 2025?",0,1.0,True
"Will Rocket Pharmaceuticals announce that its Phase 2 pivotal trial of RP-A501 for Danon disease met its co-primary endpoints by December 31, 2025?",0,0.9,True
"Will Beam Therapeutics report top-line data from the Phase I/II trial of BEAM-201 in patients with T-cell acute lymphoblastic leukemia by December 31, 2025?",0,1.0,True
"Will Moderna's Phase 3 clinical trial for its mRNA-1010 seasonal influenza vaccine meet its primary efficacy endpoints by December 31, 2024?",0,0.9,True
"Will the FDA approve Biogen and Sage Therapeutics' zuranolone for the treatment of postpartum depression by December 31, 2023?",1,1.0,True
"Will Incannex Healthcare Inc announce primary endpoint results for its Phase 2 portion of the IHL-42X RePOSA trial for obstructive sleep apnea by December 31, 2025?",1,1.0,True
"Will Novo Nordisk's Phase 3 RETHINK trial for 14 mg oral semaglutide in early Alzheimer's disease meet its primary endpoints by September 30, 2025?",0,1.0,True
"Will results from a clinical study regarding the safety of Sage Therapeutics' zuranolone (Zurzuvae) in breastfeeding women be published in a peer-reviewed journal by June 30, 2025?",1,1.0,True
"Will Ocular Therapeutix submit a Biologics License Application (BLA) to the FDA for its wet AMD hydrogel insert by December 31, 2025?",0,1.0,True
"Will Teva Pharmaceuticals or its partners announce the initiation of a Phase 3 clinical trial of laquinimod for Huntington's disease by December 31, 2025?",0,1.0,True
"Will Moderna's mRNA-1010 seasonal influenza vaccine receive FDA approval by December 31, 2026?",0,1.0,True
"Will Janssen (Johnson & Johnson) initiate a Phase 3 clinical trial for JNJ-2113 for the treatment of moderate-to-severe plaque psoriasis by June 30, 2024?",1,1.0,True
"Will Medicago's COVIFENZ COVID-19 vaccine receive FDA approval by December 31, 2023?",0,1.0,True
"Will AstraZeneca and Ionis Pharmaceuticals receive FDA approval for eplontersen for the treatment of ATTRv-polyneuropathy by December 31, 2024?",1,1.0,True
"Will the FDA approve Johnson & Johnson's guselkumab (Tremfya) for the treatment of adult patients with moderately to severely active Crohn's disease by December 31, 2025?",1,1.0,True
"Will Zoetis Inc. receive FDA approval for a new generic doramectin formulation for use in livestock by December 31, 2025?",1,0.9,True
"Will Bristol Myers Squibb (Karuna Therapeutics) receive FDA approval for KarXT (xanomeline-trospium) for the treatment of schizophrenia by September 30, 2024?",1,1.0,True
"Will the FDA withdraw its approval of the medical abortion drug mifepristone by December 31, 2025?",0,1.0,True
"Will AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan (Dato-DXd) receive FDA approval for the treatment of advanced non-small-cell lung cancer by December 31, 2024?",0,1.0,True
"Will the FDA approve Alvotech and Teva's BLA for AVT02 (adalimumab biosimilar) as a high-concentration interchangeable product by December 31, 2024?",1,1.0,True
"Will Novo Nordisk's Phase 3 trial for CagriSema in obesity (REDEFINE-1) meet its primary endpoint for weight loss by December 31, 2024?",1,1.0,True
"Will Shandong Cancer Hospital and Institute initiate a Phase 3 clinical trial for Epigallocatechin-3-Gallate (EGCG) solution in the prevention of radiation-induced dermatitis by December 31, 2025?",0,1.0,True
"Will the FDA approve Alnylam Pharmaceuticals' supplemental New Drug Application (sNDA) for vutrisiran for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM) by June 30, 2025?",1,1.0,True
"Will Legacy Healthcare receive FDA approval for Coacillium cutaneous solution for the treatment of Moderate and Severe Alopecia Areata in children and adolescents by December 31, 2025?",0,1.0,True
"Will the FDA approve MicuRx Pharmaceuticals' antibiotic contezolid (MRX-I) for the treatment of skin and soft tissue infections by December 31, 2025?",0,1.0,True
"Will 9 Meters Biopharma release Phase 2 trial results for vurolenatide in short bowel syndrome by December 31, 2022?",1,1.0,True
"Will Alnylam Pharmaceuticals' Phase 3 HELIOS-B trial of vutrisiran meet its primary endpoint of reducing cardiovascular mortality and recurrent cardiovascular events by June 30, 2024?",1,1.0,True
"Will AstraZeneca's Phase 3 datopotamab deruxtecan (Dato-DXd) trial for breast cancer meet its primary endpoint of overall survival by December 31, 2024?",0,1.0,True
"Will the Centers for Medicare and Medicaid Services (CMS) finalize its decision to restrict coverage of Biogen's Alzheimer’s drug Aduhelm to only those in clinical trials by December 31, 2022?",1,1.0,True
"Will the FDA authorize Novavax's updated JN.1 protein-based COVID-19 vaccine for emergency use by October 31, 2024?",1,1.0,True
"Will the FDA approve Vertex Pharmaceuticals and CRISPR Therapeutics' exa-cel (exagamglogene autotemcel) for the treatment of sickle cell disease by December 31, 2023?",1,1.0,True
"Will Eli Lilly's Zepbound (tirzepatide) receive FDA approval for the treatment of obstructive sleep apnea in patients with obesity by December 31, 2024?",1,1.0,True
"Will Amylyx Pharmaceuticals officially announce the withdrawal of Relyvrio (AMX0035) from the U.S. market by June 30, 2024, following the results of the Phase 3 PHOENIX trial?",1,1.0,True
"Will Amneal Pharmaceuticals receive FDA approval for its IPX203 (carbidopa/levodopa extended-release capsules) for the treatment of Parkinson disease by August 31, 2024?",1,1.0,True
"Will the FDA approve Eli Lilly's donanemab for the treatment of early symptomatic Alzheimer's disease by July 31, 2024?",1,1.0,True
"Will the FDA grant full approval to Genmab and Seagen's TIVDAK (tisotumab vedotin-tftv) for recurrent or metastatic cervical cancer by June 30, 2024?",1,1.0,True
"Will Pfizer's marstacimab receive FDA approval for the treatment of hemophilia A or B by December 31, 2024?",1,1.0,True
"Will Bristol Myers Squibb receive FDA approval for Opdivo (nivolumab) as an adjuvant treatment for resectable non-small cell lung cancer by December 31, 2024?",1,1.0,True
"Will Vaxxinity initiate a Phase 3 clinical trial for its Alzheimer's vaccine UB-311 by December 31, 2024?",0,0.9,True
"Will 9 Meters Biopharma announce positive topline results for its vurolenatide Phase 2 trial in short bowel syndrome by June 30, 2023?",0,1.0,True
"Will Moderna's Phase 3 trial for its seasonal influenza vaccine candidate, mRNA-1010, meet its primary efficacy endpoints by December 31, 2024?",0,1.0,True
"Will the IDEA-FAST consortium complete its clinical study to identify digital endpoints for fatigue and sleep by June 30, 2025?",1,1.0,True
"Will Samsung Bioepis and Biogen's ranibizumab biosimilar (Byooviz) be launched in the United States by June 30, 2022?",0,1.0,True
"Will the FDA approve Novartis's secukinumab (Cosentyx) for the treatment of moderate-to-severe hidradenitis suppurativa by December 31, 2023?",1,1.0,True
"Will the FDA approve Amylyx's AMX-0035 (also known as Albrioza) for the treatment of amyotrophic lateral sclerosis (ALS) by September 29, 2022?",1,1.0,True
"Will the U.S. Congress reauthorize the Prescription Drug User Fee Act (PDUFA) before its authority expires on September 30, 2022?",1,1.0,True
"Will Roche (Genentech) submit a New Drug Application (NDA) to the FDA for balovaptan in the treatment of autism spectrum disorder by December 31, 2025?",0,1.0,True
"Will Astellas Pharma's Phase 3 GLOW trial of zolbetuximab meet its primary endpoint of progression-free survival (PFS) by December 31, 2023?",1,1.0,True
"Will the European Medicines Agency (EMA) grant marketing authorization for Valneva's chikungunya vaccine VLA1553 (IXCHIQ) by December 31, 2024?",1,1.0,True
"Will Curio Digital Therapeutics receive FDA clearance for MamaLift Plus as a treatment for postpartum depression by December 31, 2025?",1,1.0,True
"Will Novo Nordisk's Phase 3 REDEFINE-1 trial for CagriSema in type 2 diabetes meet its primary endpoint of change in HbA1c by December 31, 2024?",0,1.0,True
"Will the Supreme Court of the United States issue a ruling that restricts the FDA's 2016 and 2021 regulatory changes for mifepristone by June 30, 2024?",0,1.0,True
"Will the FDA approve TauRx Pharmaceuticals' hydromethylthionine mesylate (HMTM) for the treatment of Alzheimer’s disease by December 31, 2024?",0,1.0,True
"Will the FDA approve Mirati Therapeutics' adagrasib for the treatment of KRAS G12C-mutated non-small cell lung cancer by December 31, 2022?",1,1.0,True
"Will Pfizer's BNT162b2 (Comirnaty) receive full FDA approval for a new variant-specific formula by December 31, 2024?",1,1.0,True
"Will Amgen and AstraZeneca initiate a Phase 3 clinical trial for tezepelumab in patients with chronic obstructive pulmonary disease (COPD) by December 31, 2025?",1,1.0,True
"Will the FDA approve Eli Lilly's donanemab for the treatment of early Alzheimer's disease by July 31, 2024?",1,1.0,True
"Will MoonLake Immunotherapeutics' Phase 2 trial of sonelokimab in psoriatic arthritis meet its primary endpoints by December 31, 2023?",1,1.0,True
"Will Karuna Therapeutics' KarXT (xanomeline-trospium) receive FDA approval for the treatment of schizophrenia by September 26, 2024?",1,1.0,True
"Will Spectrum Pharmaceuticals and Hanmi Pharmaceutical release Rolvedon (Rolontis) in the US market by December 31, 2022?",1,1.0,True
"Will the FDA approve Regeneron's bispecific antibody odronextamab for any indication by December 31, 2025?",0,1.0,True
"Will BioCardia complete the Phase 1/2 clinical trial for its NK1R+ allogeneic mesenchymal stem cell therapy (CardiALLO) for heart failure by December 31, 2025?",0,1.0,True
"Will AVM Biotechnology complete its Phase 2 clinical trial of AVM0703 for relapsed/refractory Non-Hodgkin's Lymphoma (NCT04329728) by December 31, 2025?",0,1.0,True
"Will Sage Therapeutics announce that its Phase 2 DIMENSION study of dalzanemdor in Huntington’s disease met its primary endpoint by December 31, 2024?",0,1.0,True
"Will Bharat Biotech's COVID-19 vaccine, Covaxin, receive FDA Biologics License Application (BLA) approval by December 31, 2024?",0,1.0,True
"Will the FDA approve Takeda Pharmaceutical's soticlestat for the treatment of Dravet syndrome by December 31, 2025?",0,1.0,True
"Will Bristol Myers Squibb's Phase 3 COMMANDS trial results for Reblozyl (luspatercept) lead to FDA approval for the first-line treatment of anemia in adults with lower-risk myelodysplastic syndromes by December 31, 2023?",1,1.0,True
"Will the FDA approve Lykos Therapeutics' (formerly MAPS PBC) midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD) by December 31, 2024?",0,1.0,True
"Will Roche's Phase 3 SUNMO trial (NCT05171647) comparing mosunetuzumab plus polatuzumab vedotin against rituximab plus gemcitabine and oxaliplatin meet its primary endpoint of progression-free survival by December 31, 2025?",1,1.0,True
"Will the FDA approve Johnson & Johnson's Tremfya (guselkumab) for the treatment of moderate to severe active ulcerative colitis by December 31, 2025?",1,1.0,True
"Will Pfizer's oral GLP-1 receptor agonist danuglipron receive FDA approval for the treatment of type 2 diabetes or obesity by December 31, 2025?",0,1.0,True
"Will the FDA expand the approved indication of Sarepta Therapeutics' Elevidys (delandistrogene moxeparvovec-rokl) to include Duchenne muscular dystrophy patients of all ages by July 1, 2024?",0,1.0,True
"Will the FDA lift the clinical hold on Iovance Biotherapeutics' IOV-LUN-202 trial for LN-145 by June 30, 2024?",1,1.0,True
"Will Fresenius Medical Care's 5008X Hemodialysis System become commercially available in the United States by December 31, 2025?",1,1.0,True
"Will Eli Lilly receive FDA approval for Tirzepatide specifically for the treatment of obstructive sleep apnea in adults with obesity by June 30, 2025?",1,1.0,True
"Will Viking Therapeutics initiate a Phase 3 clinical trial for VK2735 in patients with obesity by December 31, 2024?",0,1.0,True
"Will the FDA approve BridgeBio Pharma's acoramidis for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) by November 29, 2024?",1,1.0,True
"Will the FDA approve Eli Lilly's donanemab for the treatment of early symptomatic Alzheimer's disease by June 30, 2024?",0,1.0,True
"Will AstraZeneca’s Dato-DXd (datopotamab deruxtecan) receive FDA approval for the treatment of advanced or metastatic non-small cell lung cancer by December 31, 2024?",0,1.0,True
"Will a US federal court issue a ruling that identifies the FDA's approval of mifepristone as invalid by December 31, 2023?",0,1.0,True
"Will Merck and Kelun-Biotech's TROP2-targeting ADC (SKB-264) meet its primary endpoints in its Phase 3 trial for breast cancer by December 31, 2024?",1,1.0,True
"Will the European Medicines Agency (EMA) grant marketing authorization for GSK's momelotinib for the treatment of myelofibrosis by June 30, 2024?",1,1.0,True
"Will Neumora's Phase 3 trial for navacaprant in patients with major depressive disorder meet its primary endpoint by December 31, 2025?",0,1.0,True
"Will Nektar Therapeutics initiate a Phase 2b clinical trial of rezpegaldesleukin (rezpeg) for atopic dermatitis by October 31, 2023?",1,1.0,True
"Will AstraZeneca’s datopotamab deruxtecan (Dato-DXd) receive FDA approval for the treatment of advanced or metastatic breast cancer by June 30, 2025?",1,1.0,True
"Will Illumina receive FDA approval for an additional companion diagnostic claim for the TruSight Oncology Comprehensive test by December 31, 2025?",0,0.9,True
"Will BioNTech and Genentech initiate or present primary endpoint data for a Phase 2 clinical trial of autogene cevumeran in patients with resected pancreatic ductal adenocarcinoma by December 31, 2025?",1,1.0,True
"Will the FDA approve Amgen's Uplizna (inebilizumab-cdon) for the treatment of IgG4-related disease (IgG4-RD) by December 31, 2025?",1,1.0,True
"Will Adaptimmune Therapeutics' ADP-A2M4CD8 enter a Phase 2 clinical trial for gastroesophageal cancer by December 31, 2023?",1,1.0,True
"Will SaNOtize initiate a Phase 3 trial for its nitric oxide nasal spray (NONS) for COVID-19 prevention in the United States by December 31, 2022?",0,0.9,True
"Will Precigen submit a Biologics License Application (BLA) for PRGN-2012 to the FDA by December 31, 2024?",1,1.0,True
"Will Biogen's Phase 4 ENVISION confirmatory trial for Aduhelm (aducanumab) complete its primary endpoint data collection by December 31, 2026?",0,1.0,True
"Will Vertex Pharmaceuticals receive FDA approval for its vanzacaftor/tezacaftor/deutivacaftor triple combination therapy for cystic fibrosis by March 31, 2025?",1,1.0,True
"Will the FDA approve Travere Therapeutics' sparsentan for the treatment of focal segmental glomerulosclerosis (FSGS) by December 31, 2024?",0,1.0,True
"Will AstraZeneca receive FDA approval for Truqap (capivasertib) for the treatment of locally advanced or metastatic triple-negative breast cancer by December 31, 2025?",0,1.0,True
"Will the Australian Therapeutic Goods Administration (TGA) approve Servier's vorasidenib for IDH-mutant low-grade gliomas by December 31, 2025?",1,1.0,True
"Will Pfizer's Paxlovid receive full FDA approval for the treatment of COVID-19 by December 31, 2023?",1,1.0,True
"Will the FDA approve Novartis's Fabhalta (iptacopan) for the treatment of C3 glomerulopathy (C3G) by December 31, 2024?",0,1.0,True
"Will the FDA approve Karuna Therapeutics' KarXT (xanomeline-trospium) for the treatment of schizophrenia by September 26, 2024?",1,1.0,True
"Will the FDA approve Regeneron and Sanofi's Dupixent (dupilumab) for the treatment of eosinophilic esophagitis by May 31, 2022?",1,1.0,True
"Will the Medicines and Healthcare products Regulatory Agency (MHRA) approve teplizumab for the delay of type 1 diabetes in the United Kingdom by December 31, 2024?",0,1.0,True
"Will Biogen's Phase 4 ENVISION confirmatory trial for Aduhelm (aducanumab) meet its primary endpoint by December 31, 2026?",0,1.0,True
"Will the FDA approve Eli Lilly's tirzepatide for chronic weight management by December 31, 2023?",1,1.0,True
"Will the Phase 3 S2302 Pragmatica-Lung trial of ramucirumab and pembrolizumab meet its primary endpoint of overall survival by December 31, 2025?",0,1.0,True
"Will Eli Lilly release results from a head-to-head clinical trial comparing Zepbound's efficacy against CPAP machines for obstructive sleep apnea by December 31, 2025?",0,0.9,True
"Will the FDA's approval of Danco Laboratories' mifepristone (Mifeprex) be fully or partially revoked by a final court order by December 31, 2023?",0,1.0,True
"Will the U.S. Supreme Court issue a ruling that preserves the FDA's 2016 and 2021 expanded access regulations for mifepristone by June 30, 2024?",1,1.0,True
"Will the FDA approve Sage Therapeutics and Biogen's zuranolone for the treatment of postpartum depression by December 31, 2023?",1,1.0,True
"Will IQVIA enter into a new strategic partnership with a Top 10 pharmaceutical company specifically for the implementation of AI-driven adaptive clinical trial designs by December 31, 2024?",0,0.9,True
"Will Alnylam Pharmaceuticals submit a Supplemental New Drug Application (sNDA) to the FDA for vutrisiran based on the HELIOS-B trial results by December 31, 2024?",1,1.0,True
"Will the U.S. Supreme Court or a federal appellate court issue a final ruling that vacates or suspends the FDA's approval of mifepristone by December 31, 2024?",0,1.0,True
"Will Aeon Biopharma initiate a Phase 3 clinical trial of ABP-450 for the treatment of cervical dystonia by December 31, 2023?",0,1.0,True
"Will AstraZeneca's GOLDILOX Phase 2 trial of MEDI6570 meet its primary endpoint of change in total coronary plaque volume by December 31, 2025?",0,1.0,True
"Will Novo Nordisk submit CagriSema for regulatory approval to the FDA by December 31, 2025?",1,1.0,True
"Will Amgen report results from its Phase 2 clinical trial of MariTide for weight loss by December 31, 2024?",1,1.0,True
"Will Roche's atezolizumab in combination with bevacizumab and chemotherapy meet its primary endpoint for progression-free survival in a Phase 3 trial for advanced cancer by December 31, 2025?",1,0.9,True
"Will Eli Lilly's Zepbound (tirzepatide) receive FDA approval for the treatment of obstructive sleep apnea by December 31, 2024?",1,1.0,True
"Will the FDA approve AstraZeneca's supplemental application for Imfinzi (durvalumab) as a perioperative treatment for resectable non-small cell lung cancer by December 31, 2024?",1,1.0,True
"Will the FDA approve the combination of camrelizumab and rivoceranib for the frontline treatment of unresectable hepatocellular carcinoma by March 31, 2025?",0,1.0,True
Will Biogen's Phase 4 confirmatory trial (ENVISION) for aducanumab successfully meet its primary clinical endpoint for Alzheimer's disease by the FDA-mandated completion date?,0,0.9,True
"Will Glaukos Corporation receive FDA approval for iDose TR (travoprost intracameral implant) for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension by December 31, 2023?",1,1.0,True
"Will Gilead Sciences receive FDA approval for its semiannual HIV prevention drug (lenacapavir) by June 30, 2025?",1,1.0,True
"Will the FDA grant traditional approval to Eli Lilly's donanemab for the treatment of Alzheimer's disease by July 31, 2024?",1,1.0,True
"Will Incannex Healthcare's Phase II/III trial of IHL-42X for obstructive sleep apnea meet its primary endpoints by December 31, 2025?",1,1.0,True
"Will the FDA approve Ocuphire Pharma's Nyxol (phentolamine ophthalmic solution) for the reversal of pharmacologically-induced mydriasis by December 31, 2023?",1,1.0,True
"Will Eisai and Biogen's subcutaneous formulation of Leqembi (lecanemab) receive FDA approval by December 31, 2024?",0,1.0,True
"Will Stemline Therapeutics' Orserdu (elacestrant) receive European Commission marketing authorization for the treatment of patients with ER+, HER2- locally advanced or metastatic breast cancer by December 31, 2023?",1,1.0,True
"Will Eli Lilly receive FDA approval for tirzepatide in the treatment of obstructive sleep apnea by December 31, 2024?",1,1.0,True
"Will Elevation Oncology initiate a Phase 1 clinical trial for EO-3021 in the United States by December 31, 2023?",1,1.0,True
"Will AstraZeneca's Fasenra (benralizumab) receive FDA approval for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) by December 31, 2024?",1,1.0,True
"Will Merck & Co. release final 10-year follow-up efficacy data for its 9-valent human papillomavirus vaccine (Gardasil 9) in pediatric cohorts by December 31, 2024?",1,1.0,True
"Will Eisai and Biogen's Leqembi (lecanemab) receive traditional FDA approval for the treatment of Alzheimer’s disease by July 31, 2023?",1,1.0,True
"Will the FDA approve Eli Lilly's lebrikizumab for the treatment of moderate-to-severe atopic dermatitis by December 31, 2024?",1,1.0,True
"Will Reata Pharmaceuticals' Skyclarys (omaveloxolone) receive European regulatory approval for the treatment of Friedreich's ataxia by March 31, 2024?",1,1.0,True
"Will Cerevel Therapeutics receive FDA approval for tavapadon (CVL-865) for the treatment of Parkinson’s disease by December 31, 2025?",0,1.0,True
"Will the FDA grant approval to AstraZeneca and Daiichi Sankyo's Datopotamab deruxtecan (Dato-DXd) for the treatment of advanced or metastatic non-small cell lung cancer by December 31, 2024?",0,1.0,True
"Will the FDA approve Ironwood Pharmaceuticals' apraglutide for the treatment of Short Bowel Syndrome (SBS) by June 30, 2025?",0,1.0,True
"Will Vistagen Therapeutics' PALISADE-2 Phase 3 clinical trial of PH94B meet its primary endpoint by August 31, 2023?",1,1.0,True
"Will GlaxoSmithKline's RSV vaccine Arexvy receive FDA approval for use in adults aged 50-59 by June 30, 2024?",1,1.0,True
"Will Eli Lilly receive FDA approval for tirzepatide (Mounjaro) for the indication of chronic weight management by December 31, 2023?",1,1.0,True
"Will Ocugen initiate a Phase 1 clinical trial for OCU200 in diabetic macular edema by December 31, 2024?",0,1.0,True
"Will Rapa Therapeutics begin its NIH-funded Phase 2b clinical trial of RAPA-501 for the treatment of ALS by December 31, 2024?",0,1.0,True
"Will Compass Pathways' COMP360 receive FDA approval for treatment-resistant depression by December 31, 2026?",0,1.0,True
"Will Phathom Pharmaceuticals initiate a Phase 2 clinical trial of vonoprazan for the treatment of eosinophilic esophagitis (EoE) by December 31, 2024?",0,1.0,True
Did Revive Therapeutics' Phase 3 clinical trial of Bucillamine for mild-to-moderate COVID-19 achieve statistical significance on its primary clinical endpoints as reported in July 2023?,0,1.0,True
"Will AstraZeneca and Daiichi Sankyo receive FDA approval for Enhertu (trastuzumab deruxtecan) in HER2-mutant metastatic non-small cell lung cancer by August 31, 2026?",1,1.0,True
"Will UCB receive European Commission (EC) approval for rozanolixizumab for the treatment of generalized myasthenia gravis by June 30, 2024?",1,1.0,True
"Will GSK announce that the Phase 3 DREAMM-7 trial of Blenrep in second-line multiple myeloma met its primary endpoint of progression-free survival by December 31, 2023?",1,1.0,True
"Will the FDA approve Sanofi and Regeneron's Dupixent for the treatment of chronic obstructive pulmonary disorder (COPD) by September 30, 2024?",1,1.0,True
"Will the Eli Lilly drug Zepbound (tirzepatide) receive FDA approval for a new clinical indication beyond obesity and obstructive sleep apnea by December 31, 2025?",0,0.9,True
"Will Bayer receive FDA approval for the expanded use of Nubeqa (darolutamide) in combination with androgen deprivation therapy (ADT) and docetaxel for metastatic hormone-sensitive prostate cancer by December 31, 2025?",1,1.0,True
"Will Eli Lilly's SURMOUNT-5 Phase 3 trial, comparing Tirzepatide to Semaglutide for weight management, report primary endpoint results by June 30, 2025?",1,1.0,True
"Will Eli Lilly receive FDA approval for Tirzepatide (Zepbound) for the treatment of obstructive sleep apnea by December 31, 2024?",1,1.0,True
"Will TG Therapeutics announce that Briumvi (ublituximab) has received European Commission marketing authorization for relapsing forms of multiple sclerosis by June 30, 2024?",1,1.0,True
"Will Eli Lilly's tirzepatide receive FDA approval for the treatment of obstructive sleep apnea by December 31, 2024?",1,1.0,True
"Will AstraZeneca's Phase 3 DESTINY-Breast06 trial for Enhertu meet its primary endpoint of progression-free survival (PFS) in HR-low breast cancer by June 30, 2024?",1,1.0,True
"Will the FDA approve GSK's dostarlimab (Jemperli) in combination with chemotherapy for the first-line treatment of patients with metastatic non-squamous non-small cell lung cancer by December 31, 2025?",0,0.9,True
"Will Genentech's Phase 3 SUNMO trial, evaluating Polivy in combination with Lunsumio for relapsed or refractory diffuse large B-cell lymphoma, meet its primary endpoint by December 31, 2025?",1,1.0,True
"Will Florida successfully import its first shipment of prescription drugs from Canada under the FDA-approved program by December 31, 2024?",0,1.0,True
"Will the FDA grant full approval to ImmunoGen's Elahere (mirvetuximab soravtansine) for patients with folate receptor alpha-positive ovarian cancer by March 31, 2024?",1,1.0,True
"Will Sinovac Biotech release results from a dedicated Phase 3 or 4 clinical trial evaluating the safety and immunogenicity of CoronaVac in pregnant women by December 31, 2024?",0,0.9,True
"Will Alnylam's Amvuttra (vutrisiran) Phase 3 HELIOS-B trial meet its primary endpoint for ATTR cardiomyopathy by December 31, 2024?",1,1.0,True
"Will Aldeyra Therapeutics announce top-line results from the Phase 3 INVIGORATE-2 clinical trial of reproxalap by June 30, 2023?",1,1.0,True
"Will Moderna's seasonal influenza vaccine mRNA-1010 receive FDA approval by December 31, 2025?",0,1.0,True
"Will the FDA approve Novartis's Cosentyx (secukinumab) for the treatment of moderate-to-severe hidradenitis suppurativa (HS) by December 31, 2023?",1,1.0,True
"Will Bicycle Therapeutics launch the Phase 2/3 Duravelo-2 trial for BT8009 in metastatic urothelial carcinoma by March 31, 2024?",1,1.0,True
"Will the European Medicines Agency approve AstraZeneca's Imjudo (tremelimumab) in combination with Imfinzi for the treatment of advanced non-small cell lung cancer by June 30, 2023?",1,1.0,True
"Will the state of Florida successfully complete its first commercial shipment of prescription drugs imported from Canada under the FDA-approved program by December 31, 2025?",0,1.0,True
"Will Sarepta Therapeutics receive FDA accelerated approval for its Duchenne muscular dystrophy gene therapy SRP-9001 by June 30, 2023?",1,1.0,True
"Will Gilead Sciences initiate a Phase 3 clinical trial for Trodelvy (sacituzumab govitecan) in patients with small-cell lung cancer (SCLC) by December 31, 2025?",1,1.0,True
"Will Immunic Therapeutics' Phase 3 ENSURE-1 trial of vidofludimus calcium in relapsing multiple sclerosis meet its primary endpoint by December 31, 2025?",0,1.0,True
"Will the FDA approve Roche's subcutaneous formulation of Tecentriq (atezolizumab) by December 31, 2024?",1,1.0,True
"Will the FDA grant accelerated approval to Eisai's Alzheimer's drug lecanemab by January 6, 2023?",1,1.0,True
"Will AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan (Dato-DXd) receive FDA approval for the treatment of advanced or metastatic non-small cell lung cancer by December 31, 2024?",0,1.0,True
"Will the FDA expand the approved indication for Janssen and Legend Biotech's CARVYKTI to include the treatment of adults with relapsed or refractory multiple myeloma who have received at least one prior line of therapy by April 30, 2024?",1,1.0,True
"Will the FDA approve Sanofi and Regeneron's Dupixent (dupilumab) as an add-on maintenance treatment for patients with COPD by September 30, 2024?",1,1.0,True
"Will Milestone Pharmaceuticals initiate a Phase 3 clinical trial of etripamil for the treatment of atrial fibrillation with rapid ventricular rate (AFib-RVR) by December 31, 2024?",0,0.9,True
"Will Gilead Sciences report positive phase 2 results for magrolimab in solid tumors (breast, lung, or gastrointestinal cancers) by December 31, 2025?",0,1.0,True
"Will Arrowhead Pharmaceuticals announce that its Phase 3 PALISADE trial for plozasiran met its primary endpoint by December 31, 2024?",1,1.0,True
"Will the FDA grant full marketing approval for GSK's Jemperli (dostarlimab) for the treatment of mismatch repair-deficient (MMRd) rectal cancer by December 31, 2025?",0,1.0,True
"Will the FDA approve GSK's long-acting respiratory drug Exdensur for the treatment of asthma by December 31, 2026?",1,1.0,True
"Will TG Therapeutics' ublituximab receive FDA approval for the treatment of relapsing forms of multiple sclerosis by September 28, 2022?",0,1.0,True
"Will GlaxoSmithKline's bepirovirsen meet its primary endpoint in the B Well-1 Phase 3 clinical trial for chronic hepatitis B by December 31, 2025?",1,1.0,True
"Will the FDA approve Fresenius Kabi's tocilizumab biosimilar candidate by December 31, 2023?",0,1.0,True
"Will the FDA approve Xcovery's ensartinib for the treatment of patients with metastatic ALK-positive non-small cell lung cancer by December 31, 2024?",1,1.0,True
"Will the FDA approve or authorize Novavax's updated JN.1 Covid-19 vaccine for the 2024-2025 season by September 30, 2024?",1,1.0,True
"Will AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan (Dato-DXd) receive FDA approval for the treatment of advanced/metastatic non-small cell lung cancer by December 20, 2024?",0,1.0,True
"Will Janssen's oral IL-23R antagonist JNJ-2113 meet its primary endpoints in a Phase 3 clinical trial for moderate-to-severe plaque psoriasis by December 31, 2025?",1,1.0,True
"Will Pluri Inc. receive FDA approval for PLX-R18 for the treatment of Hematopoietic Acute Radiation Syndrome by December 31, 2025?",0,1.0,True
"Will Eli Lilly's Phase 3 SYNERGY-NASH trial (NCT04786275) for tirzepatide in non-alcoholic steatohepatitis meet its primary endpoints by December 31, 2024?",0,1.0,True
"Will the manufacturer of denileukin diftitox (Lymphir) complete the FDA's postmarketing study regarding the risk of visual impairment by December 31, 2026?",0,1.0,True
"Will the FDA approve Galderma's nemolizumab for the treatment of atopic dermatitis by December 31, 2024?",1,1.0,True
"Will Eli Lilly's orforglipron receive FDA approval for chronic weight management by December 31, 2025?",0,1.0,True
"Will Eli Lilly's Phase 3 SURMOUNT-MMO trial investigating the reduction of major adverse cardiovascular events for tirzepatide report results by December 31, 2024?",0,1.0,True
"Will Novo Nordisk's CagriSema Phase 3 trial (REDEFINE-1) meet its primary endpoint of weight loss superiority vs. semaglutide by March 31, 2025?",1,1.0,True
"Will Eli Lilly and Incyte's Olumiant (baricitinib) receive FDA approval for the treatment of severe alopecia areata by June 30, 2022?",1,1.0,True
"Will Gilead Sciences' ASCENT-03 Phase 3 trial of Trodelvy in triple-negative breast cancer report results by December 31, 2024?",0,1.0,True
"Will Ocular Therapeutix's Phase 3 trial of Axpaxli for wet age-related macular degeneration meet its primary endpoint by December 31, 2025?",1,1.0,True
"Will the FDA approve BeiGene's tislelizumab (Tevimbra) for first-line treatment of patients with ESCC by December 31, 2024?",0,1.0,True
"Will AstraZeneca's datopotamab deruxtecan (Dato-DXd) receive FDA approval for the treatment of advanced or metastatic non-small cell lung cancer by December 31, 2024?",0,1.0,True
"Will Johnson & Johnson's guselkumab (TREMFYA) receive FDA approval for the treatment of adult patients with moderately to severely active Crohn's disease by December 31, 2024?",0,1.0,True
"Will Novartis or MorphoSys submit a regulatory filing to the FDA for pelabresib in the treatment of myelofibrosis by December 31, 2024?",0,1.0,True
"Will the FDA approve Bristol Myers Squibb's KarXT (xanomeline-trospium) for the treatment of schizophrenia in adults by September 30, 2024?",1,1.0,True
"Will the U.S. Supreme Court issue a ruling that upholds the FDA's 2016 and 2021 regulatory changes for mifepristone by August 31, 2024?",1,1.0,True
"Will Servier Pharmaceuticals' Vorasidenib (Voranigo) receive European Commission marketing authorization for Grade 2 IDH-mutant glioma by June 30, 2025?",0,1.0,True
"Will Sarepta Therapeutics' Phase 3 EMBARK trial (SRP-9001-301) for Duchenne muscular dystrophy meet its primary endpoint of change in NSAA score by December 31, 2024?",0,1.0,True
"Will Travere Therapeutics submit a supplemental New Drug Application (sNDA) to the FDA for sparsentan in the treatment of focal segmental glomerulosclerosis (FSGS) by December 31, 2023?",0,1.0,True
"Will Eli Lilly's Phase 3 trial of tirzepatide for the treatment of obstructive sleep apnea (SURMOUNT-OSA) report positive results for its primary endpoint by June 30, 2024?",1,1.0,True
"Will REGENXBIO and AbbVie's ABBV-RGX-314 receive FDA approval for the treatment of wet age-related macular degeneration by December 31, 2026?",0,1.0,True
"Will BridgeBio Pharma announce topline results from the Phase 3 FORTIFY trial interim analysis of BBP-418 by December 31, 2025?",1,1.0,True
"Will the Phase 3 trial of IO102-IO103 in combination with pembrolizumab meet its primary endpoint of progression-free survival in patients with advanced melanoma by December 31, 2025?",0,1.0,True
"Will Cantex Pharmaceuticals receive FDA approval to initiate Phase 2 clinical trials for its COVID-19 treatment based on Human Alveolus Chip data by December 31, 2022?",1,0.9,True
"Will Astellas Pharma's Izervay (avacincaptad pegol) receive a positive Phase 3 top-line result for its long-term safety study in geographic atrophy by December 31, 2024?",0,1.0,True
"Will the FDA approve a supplemental New Drug Application (sNDA) for colchicine (Lodoco) specifically for the prevention of atrial fibrillation or myocardial injury after non-cardiac thoracic surgery by December 31, 2025?",0,1.0,True
"Will AskBio initiate a Phase II clinical trial for the AB-1005 gene therapy in patients with Parkinson's disease by June 30, 2024?",1,1.0,True
"Will Novo Nordisk's mimic Phase 3 trial for weight management meet its primary endpoints by December 31, 2025?",0,1.0,True
"Will CG Oncology's Phase 3 BOND-003 trial for cretostimogene grenadenorepvec in high-risk NMIBC meet its primary endpoint of complete response rate by December 31, 2024?",1,1.0,True
"Will Iterum Therapeutics' antibiotic treatment sulopenem receive FDA approval for the treatment of uncomplicated urinary tract infections (uUTI) by December 31, 2024?",1,1.0,True
"Will the FDA approve GSK's gepotidacin for the treatment of uncomplicated urinary tract infections (uUTI) by December 31, 2024?",0,1.0,True
"Will Sarepta Therapeutics' Phase 3 EMBARK trial (SRP-9001-301) for Duchenne muscular dystrophy meet its primary endpoint of change in NSAA score by December 31, 2024?",0,1.0,True
"Will Futura Medical's MED3000 receive FDA marketing authorization for over-the-counter use by March 31, 2023?",0,1.0,True
"Will Vertex Pharmaceuticals' CRISPR treatment Casgevy overcome its rollout bottleneck and achieve commercial use in at least 5 treatment centers by June 30, 2026?",1,1.0,True
"Will Biogen's Phase 3 trial of lecanemab meet its primary endpoint for slowing cognitive decline in Alzheimer's disease patients by December 31, 2022?",1,1.0,True
"Will Gilead Sciences' Remdesivir (Veklury) receive expanded FDA approval for the treatment of non-hospitalized pediatric patients with COVID-19 by December 31, 2022?",1,1.0,True
"Will the FDA approve bluebird bio's gene therapy beti-cel (Zynteglo) for patients with beta thalassemia by August 19, 2022?",1,1.0,True
"Will the FDA approve Neurocrine Biosciences' valbenazine (INGREZZA) for the treatment of chorea associated with Huntington's disease by December 31, 2023?",1,1.0,True
"Will Amylyx Therapeutics announce that its Phase 3 PHOENIX trial of AMX0035 for ALS met its primary endpoint by March 31, 2024?",0,1.0,True
"Will Eli Lilly's tirzepatide receive FDA approval for the treatment of heart failure with preserved ejection fraction (HFpEF) by December 31, 2025?",0,1.0,True
"Will Annexon Biosciences complete patient enrollment for the Phase 3 clinical trial of ANX005 in Guillain-Barre syndrome by December 31, 2023?",1,1.0,True
"Will Heartseed and Novo Nordisk's Phase 1/2 clinical study of HS-001 for heart failure reach its primary completion date by December 31, 2025?",1,1.0,True
"Will Calliditas Therapeutics' Phase 2 trial of setanaxib in combination with Keytruda for head and neck cancer (NCT05323656) be completed by June 30, 2024?",0,1.0,True
"Will Bristol Myers Squibb's antipsychotic KarXT (xanomeline-trospium) receive FDA approval for the treatment of schizophrenia by September 26, 2024?",1,1.0,True
"Will Pliant Therapeutics release interim 12-week data from the 320 mg cohort of the INTEGRIS-IPF Phase 2a trial by March 31, 2023?",1,1.0,True
"Will Oncternal Therapeutics release additional clinical data from its Phase 1/2 trial of ONCT-808 for aggressive B-cell lymphomas by December 31, 2024?",1,1.0,True
"Will Pfizer and Valneva's Lyme disease vaccine candidate (VLA15) receive FDA approval for use in adults by December 31, 2025?",0,1.0,True
"Will the FDA approve Galderma's nemolizumab for the treatment of atopic dermatitis by December 31, 2024?",1,0.9,True
"Will Eli Lilly's retatrutide meet its primary endpoint in a Phase 3 TRIUMPH clinical trial for chronic weight management by December 31, 2025?",1,1.0,True
"Will BenevolentAI initiate a Phase 3 clinical trial for BEN-2293 in patients with atopic dermatitis by December 31, 2025?",0,1.0,True
"Will NorthSea Therapeutics' Phase 2b trial for its lead candidate icosabutate in NASH meet its primary endpoint by December 31, 2024?",0,1.0,True
"Will the PEC-Direct Phase 1/2 clinical trial (NCT03163511) meet its primary endpoint of an increase in meal-stimulated plasma C-peptide above the limit of detection (0.03 nmol l−1) in at least 50% of the enrolled cohort by December 31, 2024?",0,0.9,True
"Will the FDA approve AbbVie's Skyrizi (risankizumab) for the treatment of ulcerative colitis by December 31, 2024?",1,1.0,True
"Will Ligand Pharmaceuticals' berdazimer gel (Zelsuvmi) receive FDA approval for the treatment of molluscum contagiosum by January 31, 2024?",1,1.0,True
"Will Novartis receive FDA label expansion for Pluvicto in taxane-naive metastatic castration-resistant prostate cancer patients based on the PSMAfore Phase 3 trial results by December 31, 2024?",0,1.0,True
"Will Pfizer's Daurismo (glasdegib) retain its FDA approval for use with a continuous manufacturing process through December 31, 2025?",1,0.9,True
"Will Sage Therapeutics and Biogen receive FDA approval for zuranolone (ZURZUVAE) for the treatment of Major Depressive Disorder (MDD) by December 31, 2025?",0,1.0,True
"Will Blade Therapeutics report top-line Phase 2 clinical trial results for its lead candidate cudratrigene (BLD-2660) in patients with idiopathic pulmonary fibrosis by December 31, 2024?",0,0.9,True
"Will Q32 Bio initiate its Phase 2 clinical trial of ADX-914 for the treatment of atopic dermatitis by December 31, 2022?",1,1.0,True
"Will Perrigo's over-the-counter birth control pill Opill be available for purchase in U.S. retail stores by March 31, 2024?",1,1.0,True
"Will the FDA approve AstraZeneca's danicopan as an add-on therapy for patients with paroxysmal nocturnal hemoglobinuria (PNH) by December 31, 2024?",1,1.0,True
"Will Sun Pharmaceutical Industries commercially launch Leqselvi (deuruxolitinib) in the United States by December 31, 2024?",0,1.0,True
"Will ALX Oncology start the Phase 3 clinical trial of evorpacept for HER2-positive advanced gastric/gastroesophageal junction cancer by December 31, 2024?",0,0.95,True
"Will the FDA officially remove oral phenylephrine from the list of over-the-counter medications 'Generally Recognized as Safe and Effective' (GRASE) by December 31, 2025?",0,1.0,True
"Will the FDA approve CymaBay Therapeutics' seladelpar for the treatment of primary biliary cholangitis by December 31, 2024?",1,1.0,True
"Will Alembic Pharmaceuticals receive FDA approval for at least one additional ANDA in the dermatology therapeutic area by December 31, 2024?",1,1.0,True
"Will Takeda initiate a Phase 3 clinical trial of TAK-861 in patients with narcolepsy type 1 by September 30, 2024?",1,1.0,True
"Will the FDA grant full traditional approval to Biogen's Qalsody (tofersen) for the treatment of SOD1-ALS by April 30, 2024?",0,1.0,True
"Will Vir Biotechnology report results from its Phase 2 trials for hepatitis B or hepatitis D involving VIR-2218 or VIR-3434 by December 31, 2023?",1,1.0,True
Did the FDA officially delay the enforcement of the final Guidance for Industry #256 regarding veterinary drug compounding beyond its initial October 2022 target?,1,1.0,True
"Will the FDA approve Sandoz's denosumab biosimilar (prescribed for osteoporosis and bone metastases) by June 30, 2024?",1,1.0,True
"Will Valneva's Phase 3 clinical trial for its chikungunya vaccine candidate (VLA1553) meet its primary endpoint of inducing a seroprotective antibody response by December 31, 2023?",1,1.0,True
"Will Formycon AG and Klinge Biopharma's FYB203/AHZANTIVE (aflibercept-mrbb) be commercially launched in the United States by December 31, 2024?",0,1.0,True
"Will the FDA approve AstraZeneca's danicopan as an add-on therapy for paroxysmal nocturnal haemoglobinuria (PNH) by December 31, 2024?",1,1.0,True
"Will Alnylam Pharmaceuticals receive FDA approval for vutrisiran (Amvuttra) for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM) by June 30, 2025?",1,1.0,True
"Will the FDA approve Poxel and Roivant Sciences' imeglimin for the treatment of type 2 diabetes by December 31, 2023?",0,1.0,True
"Will VivaVision Biotech initiate Phase 3 clinical trials for VVN461 ophthalmic solution for the treatment of postoperative inflammation following cataract surgery by December 31, 2025?",0,0.9,True
"Will the FDA approve Johnson & Johnson's nipocalimab for the treatment of generalized myasthenia gravis (gMG) by December 31, 2025?",1,1.0,True
"Will Vertex Pharmaceuticals and CRISPR Therapeutics receive FDA approval for Casgevy (exagamglogene autotemcel) to treat transfusion-dependent beta thalassemia by March 30, 2024?",1,1.0,True
"Will Arcellx initiate its iMMagine Phase 2 clinical trial for relapsed/refractory multiple myeloma by December 31, 2022?",1,1.0,True
"Will Kyverna Therapeutics release top-line data from the KYSA-8 Phase 2 clinical trial of KYV-101 for stiff-person syndrome by December 31, 2025?",1,1.0,True
"Will Humanetics Corporation's drug BIO 300 receive FDA Emergency Use Authorization (EUA) for the prevention of acute radiation syndrome by December 31, 2025?",0,1.0,True
"Will the FDA approve Vertex Pharmaceuticals' suzetrigine (VX-548) for the treatment of acute pain by December 31, 2024?",0,1.0,True
"Will Vertex Pharmaceuticals' VX-548 (suzetrigine) receive FDA approval for the treatment of moderate-to-severe acute pain by January 30, 2025?",0,1.0,True
"Will the FDA approve Intercept Pharmaceuticals' Ocaliva (obeticholic acid) for the treatment of NASH patients with liver fibrosis by June 30, 2023?",0,1.0,True
"Will Zoetis receive FDA approval for a new monoclonal antibody therapeutic for canine or feline indications by December 31, 2025?",0,1.0,True
"Will Vir Biotechnology and GSK initiate a Phase 3 clinical trial for VIR-2482 for the prevention of influenza A by December 31, 2024?",0,1.0,True
"Will Swing Therapeutics' Stanza digital therapy demonstrate a statistically significant response rate on the PGIC Scale compared to control in the PROSPER-FM Phase 3 trial results presented by December 31, 2023?",1,1.0,True
"Will Bristol Myers Squibb's KarXT (xanomeline-trospium) receive FDA approval for the treatment of schizophrenia by September 26, 2024?",1,1.0,True
"Will the FDA approve Ionis Pharmaceuticals' drug olezarsen for familial chylomicronemia syndrome by December 31, 2024?",1,1.0,True
Will the CLEAR Outcomes trial meeting its primary endpoint for reducing major adverse cardiovascular events (MACE) be presented at the ACC 2023 conference with a statistically significant result?,1,1.0,True
"Will Gilead Sciences receive FDA approval for a new repurposed indication of Remdesivir (Veklury) by December 31, 2025?",0,1.0,True
"Will Sarepta Therapeutics' MIS51ON (NCT03992430) Phase 3 trial for Exondys 51 be completed by December 31, 2026?",1,1.0,True
"Will Novo Nordisk's CagriSema Phase 3 trial for weight management meet its primary endpoints by June 30, 2025?",1,1.0,True
"Will Karuna Therapeutics' KarXT EMERGENT-3 Phase 3 trial (NCT04738123) for schizophrenia meet its primary endpoint by June 30, 2024?",1,1.0,True
"Will Denali Therapeutics release safety and biomarker data from a clinical trial of DNL919 by December 31, 2022?",0,1.0,True
"Will Annovis Bio initiate a Phase 3 clinical trial of buntanetap for the treatment of Alzheimer’s disease by June 30, 2025?",1,1.0,True
"Will Jiangsu Hengrui Pharmaceuticals receive FDA approval for dalpiciclib in combination with endocrine therapy for the treatment of HR+/HER2- advanced breast cancer by December 31, 2025?",0,1.0,True
"Will Alvotech receive FDA approval for AVT06, its biosimilar to Eylea (aflibercept), by December 31, 2025?",0,0.9,True
"Will Novo Nordisk's REDEFINE-1 Phase 3 trial for CagriSema meet its primary endpoint for weight loss by December 31, 2024?",1,1.0,True
"Will AbbVie and Genmab receive FDA approval for epcoritamab (Epkinly) for the treatment of relapsed or refractory follicular lymphoma by December 31, 2024?",1,1.0,True
"Will AbbVie's upadacitinib receive European Commission approval for the treatment of pediatric patients with moderately to severely active ulcerative colitis by December 31, 2024?",0,1.0,True
"Will TheracosBio's Brenzavvy (bexagliflozin) receive FDA approval for the treatment of weight loss in patients without diabetes by December 31, 2025?",0,1.0,True
"Will On Target Laboratories receive FDA approval for Cytalux (pafolacianine) for use in identifying brain cancer tumors by December 31, 2025?",0,1.0,True
"Will Axsome Therapeutics announce that its Phase 3 trial of AXS-12 for the treatment of narcolepsy met its primary endpoint by December 31, 2024?",1,1.0,True
"Will Azurity Pharmaceuticals commercially launch Zonisade in the United States by December 31, 2022?",1,1.0,True
"Will Infinity Pharmaceuticals announce top-line results from a Phase 2 trial of eganelisib in head and neck cancer by December 31, 2025?",0,0.9,True
"Will UCB's Rystiggo (rozanolixizumab) receive marketing authorization from the European Commission for the treatment of generalized myasthenia gravis by March 31, 2024?",1,1.0,True
"Will Eli Lilly's Tirzepatide receive FDA approval for the treatment of heart failure with preserved ejection fraction (HFpEF) by December 31, 2024?",0,1.0,True
"Will Takeda submit regulatory filings for soticlestat (TAK-935) for its target indications by March 31, 2025?",0,1.0,True
"Will Bharat Biotech's intranasal COVID-19 vaccine (BBV154) receive emergency use authorization in India by January 31, 2023?",1,1.0,True
"Will Genelux's Phase 3 trial of Olvi-Vec (Oncoprex) for the treatment of platinum-resistant ovarian cancer meet its primary endpoint by December 31, 2025?",0,1.0,True
"Will Novartis announce that remibrutinib met its primary endpoint in the Phase 3 clinical trials for relapsing forms of multiple sclerosis by December 31, 2025?",0,1.0,True
"Will Eli Lilly's Phase 3 trial of tirzepatide for the treatment of obstructive sleep apnea (SURMOUNT-OSA) meet its primary endpoint by June 30, 2024?",1,1.0,True
"Will Opthea's Phase 3 ShORe trial for sozinibercept in wet age-related macular degeneration meet its primary endpoint by June 30, 2025?",0,1.0,True
"Will Kazia Therapeutics present full data from the paxalisib arm of the GBM AGILE trial (NCT03970447) at a scientific meeting by December 31, 2024?",0,1.0,True
"Will Eli Lilly's Zepbound (tirzepatide) receive expanded FDA approval for the treatment of obstructive sleep apnea in adults with obesity by December 31, 2024?",1,1.0,True
"Will Eli Lilly's mirikizumab (Omvoh) receive FDA approval for the treatment of Crohn's disease by December 31, 2024?",0,1.0,True
"Will AstraZeneca and Daiichi Sankyo's Phase 3 DESTINY-Breast05 trial evaluating Enhertu versus T-DM1 meet its primary endpoint of invasive disease-free survival by December 31, 2025?",1,1.0,True
"Will China's National Medical Products Administration (NMPA) approve Innovent Biologics' mazdutide for the treatment of type 2 diabetes by December 31, 2025?",1,1.0,True
"Will the FDA grant full traditional approval to Biogen and Eisai's Alzheimer's treatment lecanemab (Leqembi) by July 31, 2023?",1,1.0,True
"Will the U.S. Supreme Court issue a ruling that maintains the current FDA approval and access conditions for Danco Laboratories' mifepristone by July 31, 2024?",1,1.0,True
"Will Henlius (Shanghai Henlius Biotech) initiate a Phase 3 clinical trial for its daratumumab biosimilar HLX15 by June 30, 2025?",0,1.0,True
"Will Biogen and Eisai's Alzheimer's drug lecanemab meet its primary endpoint in the Phase 3 Clarity AD clinical trial by December 31, 2022?",1,1.0,True
"Will Pfizer's abrocitinib (Cibinqo) receive FDA approval for children aged 2 to <12 years with moderate-to-severe atopic dermatitis by December 31, 2024?",0,1.0,True
"Will AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan (Dato-DXd) receive FDA approval for the treatment of advanced non-small-cell lung cancer (NSCLC) by December 31, 2024?",0,1.0,True
"Will Viridian Therapeutics announce topline results from its THRIVE-2 Phase 3 trial of VRDN-001 in chronic Thyroid Eye Disease by December 31, 2024?",1,1.0,True
"Will Eli Lilly and Boehringer Ingelheim's Jardiance receive a label expansion from the FDA for heart failure with preserved ejection fraction (HFpEF) by December 31, 2022?",1,1.0,True
"Will Calliditas Therapeutics receive full FDA approval for Tarpeyo (Nefecon) to treat IgA nephropathy by June 30, 2024?",1,1.0,True
"Will American Gene Technologies initiate a Phase 2 clinical trial for its HIV cell therapy AGT103-T by December 31, 2024?",0,1.0,True
"Will the NETTER-P (NCT04711135) clinical trial for lutetium Lu 177 dotatate in pediatric patients reach its primary completion date by December 31, 2025?",0,1.0,True
"Will Roche or Prothena announce that a Phase 2b or Phase 3 clinical trial of prasinezumab for Parkinson’s disease met its primary endpoint by December 31, 2025?",0,1.0,True
"Will Veru Inc.'s SARM candidate Enobosarm (ostarine) receive FDA approval for any indication by December 31, 2025?",0,1.0,True
"Will StemCyte advance its HPC, Cord Blood therapy for Post-COVID Syndrome to a Phase 3 clinical trial by December 31, 2025?",0,1.0,True
"Will Amylyx Pharmaceuticals voluntarily withdraw Relyvrio from the U.S. market by December 31, 2024?",1,1.0,True
"Will the FDA approve Vertex Pharmaceuticals' suzetrigine for the treatment of moderate to severe acute pain by January 30, 2025?",1,1.0,True
"Will 4Moving Biotech report final data from its Phase 1 trial (NCT05419856) of 4P004 for knee osteoarthritis by March 31, 2024?",0,0.9,True
"Will Calico Life Sciences' ABBV-CLS-7262 meet its primary endpoint in the HEALEY ALS Platform Trial by June 30, 2025?",0,1.0,True
"Will Capricor Therapeutics' HOPE-3 Phase 3 trial (NCT05126758) for CAP-1002 in Duchenne muscular dystrophy reach its primary completion date by December 31, 2024?",0,1.0,True
"Will the FDA approve Karuna Therapeutics' KarXT (xanomeline-trospium) for the treatment of schizophrenia in adults by September 26, 2024?",1,1.0,True
"Will the FDA approve Merck & Co.'s sotatercept for the treatment of pulmonary arterial hypertension (PAH) by March 31, 2024?",1,1.0,True
"Will AstraZeneca's Phase 3 TROPION-Lung01 trial meet its primary endpoint of overall survival for datopotamab deruxtecan by December 31, 2024?",0,1.0,True
"Will MindMed announce results from its Phase 3 Emerge Study (MM120-310) for major depressive disorder by December 31, 2026?",1,1.0,True
"Will EyeBiotech Limited (EyeBio) initiate a Phase 1b/2 clinical trial for Restoret (EYE103) by June 30, 2023?",1,1.0,True
"Will AstraZeneca's Phase 3 trial for Dato-DXd (TROPION-Lung01) receive FDA approval for the treatment of non-small cell lung cancer by December 31, 2024?",0,1.0,True
"Will Aurion Biotech initiate Phase 3 pivotal trials for AURN001 in patients with corneal endothelial dysfunction by December 31, 2025?",0,1.0,True
"Will the FDA approve Johnson & Johnson's nipocalimab for the treatment of generalized myasthenia gravis (gMG) by December 31, 2025?",1,1.0,True
"Will the FDA approve pitolisant for the treatment of cataplexy in pediatric narcolepsy by March 1, 2026?",1,1.0,True
"Will the FDA grant traditional approval to Lykos Therapeutics' Midomafetamine (MDMA) for the treatment of Post-Traumatic Stress Disorder by August 31, 2024?",0,1.0,True
"Will Eli Lilly's tirzepatide advance to Phase 3 clinical trials for the treatment of non-alcoholic steatohepatitis (NASH) by December 31, 2024?",1,1.0,True
"Will Amgen's Phase 3 OCEAN(a)-DOSE trial for Olpasiran meet its primary endpoint for reduction in Lp(a) levels by December 31, 2025?",1,1.0,True
"Will Gilead Sciences or its partners initiate a Phase 3 placebo-controlled clinical trial of ranolazine for muscle cramps in amyotrophic lateral sclerosis (ALS) by December 31, 2025?",0,0.9,True
"Will Short Wave Pharma initiate its Phase I/IIa clinical trial for its psilocybin-based anorexia nervosa treatment by June 30, 2023?",0,1.0,True
"Will Biogen and Eisai's Phase 3 AHEAD 3-45 study of lecanemab in preclinical Alzheimer's disease meet its primary endpoint by December 31, 2026?",0,1.0,True
"Will Karuna Therapeutics initiate its Phase 3 clinical program for KarXT in the treatment of psychosis in Alzheimer's disease by September 30, 2022?",1,1.0,True
"Will the FDA approve Karuna Therapeutics' KarXT (xanomeline-trospium) for the treatment of schizophrenia by September 26, 2024?",1,1.0,True
"Will Moderna file for regulatory approval of its mRNA-1010 seasonal influenza vaccine by December 31, 2024?",0,1.0,True
"Will Vertex Pharmaceuticals' pain medication VX-548 receive FDA approval by December 31, 2024?",0,1.0,True
"Will AstraZeneca's Phase 3 SERENA-4 trial (NCT04711252) evaluating camizestrant meet its primary endpoint of progression-free survival by December 31, 2024?",0,1.0,True
"Will Novo Nordisk's CagriSema Phase 3 trial (REDEFINE-1) meet its primary endpoint of reduction in HbA1c by December 31, 2024?",0,1.0,True
"Will AbbVie's phase 2 trial of emraclidine for schizophrenia meet its primary endpoint by December 31, 2024?",0,1.0,True
"Will the FDA grant approval for Emergent BioSolutions' over-the-counter Narcan (naloxone) nasal spray by March 31, 2023?",1,1.0,True
"Will the Centers for Medicare & Medicaid Services (CMS) finalize a National Coverage Determination that limits Medicare coverage for Biogen's Aduhelm (aducanumab) to patients in clinical trials by April 30, 2022?",1,1.0,True
"Will Phaxiam Therapeutics (formerly Pherecydes Pharma) announce positive results from a clinical trial for its phage therapy pipeline by December 31, 2025?",0,1.0,True
"Will Pfizer's RSV drug candidate sisunatovir (acquired from ReViral) successfully meet its primary endpoint in a Phase 2 clinical trial by December 31, 2024?",0,1.0,True
"Will Intra-Cellular Therapies submit a Supplemental New Drug Application (sNDA) to the FDA for lumateperone for the prevention of relapse in schizophrenia by June 30, 2025?",0,1.0,True
"Will EnGeneIC's Armed Nanocell Drug Conjugate (ANDC) treatment for pancreatic cancer successfully complete a Phase 2 clinical trial by December 31, 2025?",0,0.9,True
"Will Sarepta Therapeutics receive FDA accelerated approval for its Duchenne muscular dystrophy gene therapy SRP-9001 (elevidys) for the treatment of ambulatory pediatric patients by July 1, 2023?",1,1.0,True
"Will 9 Meters Biopharma commence the Phase 3 clinical trial of vurolenatide for short bowel syndrome by December 31, 2022?",0,1.0,True
"Will the FDA grant full qualification to the AI-based measurement of metabolic dysfunction-associated steatohepatitis (AIM-MASH) tool for use in clinical trials by December 31, 2025?",1,1.0,True
"Will the FDA grant full approval to Biogen and Eisai's Alzheimer’s treatment lecanemab by September 30, 2023?",1,1.0,True
"Will Sorrento Therapeutics release top-line data from its Phase 3 trial of Ovydso (STI-1558) for COVID-19 by September 30, 2023?",1,1.0,True
"Will Nevro's Senza HFX iQ spinal cord stimulation system receive CE mark approval in Europe by December 31, 2024?",1,1.0,True
"Will Neumora Therapeutics announce that its Phase 3 KOALAS trial of navacaprant met its primary endpoint for major depressive disorder by December 31, 2024?",0,1.0,True
"Will the FDA approve Geron's imetelstat for the treatment of transfusion-dependent anemia in patients with lower-risk myelodysplastic syndromes by June 30, 2024?",1,1.0,True
"Will the FDA approve Eli Lilly's Jaypirca (pirtobrutinib) for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) by December 31, 2024?",1,1.0,True
"Will PTC Therapeutics submit a New Drug Application (NDA) to the FDA for vatiquinone (PTC743) for the treatment of Friedreich Ataxia by December 31, 2024?",1,1.0,True
"Will Intra-Cellular Therapies receive FDA approval for lumateperone (Caplyta) as an adjunctive treatment for major depressive disorder (MDD) by December 31, 2024?",0,1.0,True
"Will Genentech's mosunetuzumab (Lunsumio) receive full FDA approval for relapsed or refractory follicular lymphoma by December 31, 2025?",1,1.0,True
"Will Johnson & Johnson's antidepressant Spravato (esketamine) receive FDA approval for a new pediatric indication by December 31, 2025?",0,1.0,True
"Will Vertex Pharmaceuticals receive FDA approval for the triple-combination therapy Kaftrio (elexacaftor/tezacaftor/ivacaftor) for use in children with cystic fibrosis aged 1 to 2 years by December 31, 2025?",0,1.0,True
"Will Caliway Biopharmaceuticals initiate a global pivotal Phase III study for CBL-514 by December 31, 2025?",1,1.0,True
"Will Florida successfully import its first shipment of prescription drugs from Canada under the FDA-authorized program by December 31, 2024?",0,1.0,True
"Will Boan Biotech's BA5101 (dulaglutide biosimilar) receive marketing approval from China's National Medical Products Administration (NMPA) by December 31, 2025?",1,1.0,True
"Will the FDA grant approval to Eli Lilly's donanemab for the treatment of early-stage Alzheimer's disease by June 30, 2024?",0,1.0,True
"Will Eli Lilly's Alzheimer's treatment donanemab receive FDA approval by August 31, 2024?",1,0.9,True
"Will Novartis's Phase 3 PSMAction trial of Pluvicto for prostate cancer meet its primary endpoint of radiographic progression-free survival by December 31, 2024?",0,0.9,True
"Will Palatin Technologies initiate a second Phase 3 clinical trial for PL9643 for the treatment of dry eye disease by December 31, 2024?",0,1.0,True
"Will the FDA grant traditional (full) approval to Eisai and Biogen's lecanemab (Leqembi) for the treatment of Alzheimer's disease by September 30, 2023?",1,1.0,True
"Will Citius Pharmaceuticals receive FDA approval for denileukin diftitox (LYTENAVA) for the treatment of cutaneous T-cell lymphoma by August 31, 2024?",1,1.0,True
"Will Delix Therapeutics announce the completion of a Phase 1 clinical trial for its lead candidate DLX-001 by December 31, 2024?",1,1.0,True
"Will Madrigal Pharmaceuticals receive FDA approval for Resmetirom (Rezdiffra) for the treatment of NASH/MASH by March 31, 2024?",1,1.0,True
"Will Chinook Therapeutics resume dosing in the Phase 1 trial of CHK-336 for hyperoxalurias by December 31, 2023?",0,1.0,True
"Will Novavax's Phase 3 trial for its COVID-19-Influenza Combination (CIC) vaccine meet its primary immunogenicity endpoints by December 31, 2024?",0,1.0,True
"Will Kyverna Therapeutics report that its Phase 2 study of KYV-101 in patients with myasthenia gravis met its primary endpoint by December 31, 2025?",1,1.0,True
"Will AstraZeneca's Phase 3 trial of datopotamab deruxtecan (Dato-DXd) for non-small cell lung cancer meet its primary endpoint of overall survival by December 31, 2024?",0,1.0,True
"Will Alnylam and Roche report that the Phase 2 KARDIA-1 trial of zilebesiran for hypertension met its primary endpoint by June 30, 2024?",1,1.0,True
"Will GEIS (Spanish Group for Research on Sarcomas) initiate or announce a Phase 3 clinical trial of nab-paclitaxel for desmoid tumors by December 31, 2025?",0,0.9,True
"Will Eli Lilly's tirzepatide receive FDA approval for the treatment of obstructive sleep apnea by June 30, 2025?",1,1.0,True
"Will Brooklyn ImmunoTherapeutics' IRX-2 immunotherapy meet its primary endpoint of event-free survival in the Phase 2 INSPIRE trial for oral cavity cancer by July 31, 2022?",0,1.0,True
"Will the Centers for Medicare & Medicaid Services (CMS) finalize the National Coverage Determination for Biogen's Alzheimer's drug Aduhelm (aducanumab) by April 30, 2022?",1,1.0,True
"Will MorphoSys submit a New Drug Application (NDA) for pelabresib in myelofibrosis to the FDA by September 30, 2024?",0,1.0,True
"Will Mirati Therapeutics initiate a Phase 1 clinical trial for MRTX1133 in patients with KRAS G12D-mutated solid tumors by December 31, 2023?",1,1.0,True
"Will the FDA approve AstraZeneca's supplemental biologics license application for perioperative durvalumab in resectable non-small cell lung cancer (NSCLC) by December 31, 2024?",1,1.0,True
Did the SPEAD-A extension study find a statistically significant reduction in the primary endpoint of major cardiovascular events for the early alogliptin initiation group compared to the conventional treatment group during the 520-week follow-up period?,0,1.0,True
"Will Karyopharm Therapeutics' Phase 3 SENTRY trial of selinexor in combination with ruxolitinib reach its primary endpoint of Spleen Volume Reduction (SVR35) by December 31, 2025?",0,1.0,True
"Will the FDA approve AstraZeneca's osimertinib (Tagrisso) for the treatment of unresectable Stage III EGFR-mutated non-small cell lung cancer based on the Phase 3 LAURA trial results by February 28, 2025?",1,1.0,True
"Will the FDA approve a supplemental Biologics License Application (sBLA) for any new indication for ADMA Biologics' Asceniv by December 31, 2025?",0,1.0,True
"Will Akero Therapeutics report that the Phase 2b SYMMETRY trial of efruxifermin met its primary endpoint by December 31, 2023?",0,1.0,True
"Will Eli Lilly receive FDA approval for its Alzheimer's drug donanemab by December 31, 2024?",1,1.0,True
"Will the U.S. Supreme Court issue a ruling that preserves the FDA's current approval and distribution regulations for mifepristone by July 1, 2024?",1,1.0,True
"Will Brii Biosciences report that the Phase 2 study of BRII-179 in combination with PEG-IFNα met its primary endpoint for functional cure at the 48-week post-treatment follow-up by December 31, 2024?",0,0.9,True
"Will the European Commission grant marketing authorization for Takeda's fruquintinib for the treatment of adult patients with metastatic colorectal cancer by June 30, 2024?",1,1.0,True
"Will Pfizer's CIBINQO (abrocitinib) receive regulatory approval for the treatment of atopic dermatitis in children under 12 years of age by December 31, 2025?",0,1.0,True
"Will Eli Lilly's tirzepatide receive regulatory approval for weight management in China by December 31, 2025?",1,1.0,True
"Will Novocure's TTFields technology receive FDA approval for second-line non-small cell lung cancer (2L NSCLC) by December 31, 2024?",1,1.0,True
"Will the European Commission grant marketing authorization for Janssen-Cilag's Tecvayli (teclistamab) for the treatment of multiple myeloma by December 31, 2022?",1,0.9,True
"Will Pfizer and Valneva submit a Biologics License Application (BLA) to the FDA for the Lyme disease vaccine candidate VLA15 by December 31, 2025?",0,1.0,True
"Will Sage Therapeutics and Biogen announce the initiation of a Phase 3 clinical trial for SAGE-324 (BIIB124) in any indication by December 31, 2025?",0,1.0,True
"Will Takeda Pharmaceuticals initiate global Phase 3 clinical trials for TAK-861 in patients with narcolepsy type 1 by December 31, 2024?",1,1.0,True
"Will Emmecell Biotech's E02002 Phase 1b trial (NCT04894110) for corneal edema report primary endpoint safety data by December 31, 2025?",1,1.0,True
"Will Glyscend Therapeutics report initial clinical data from its Phase 2 trial of GLY-200 for type 2 diabetes by June 30, 2023?",1,1.0,True
"Will Akero Therapeutics initiate a Phase 3 clinical trial for efruxifermin in patients with MASH (NASH) by December 31, 2024?",1,1.0,True
"Will GlaxoSmithKline's Arexvy (RSVPreF3) receive FDA approval for use in adults aged 50 to 59 by June 30, 2024?",1,1.0,True
"Will Roche and Prothena's prasinezumab meet the primary endpoint of slowing clinical decline in the Phase 2b PADOVA trial for Parkinson's disease by December 31, 2025?",0,1.0,True
"Will Pfizer's RSV vaccine (Abrysvo) receive FDA approval for use in infants via maternal immunization by August 31, 2023?",1,1.0,True
"Will Helixmith receive positive top-line Phase 3 clinical trial results for Engensis (VM202) in critical limb ischemia by December 31, 2025?",0,0.9,True
"Will Novo Nordisk's CagriSema Phase 3 trial meet its primary endpoints for weight loss in participants with obesity by December 31, 2024?",1,1.0,True
"Will Intrinsic Medicine initiate a Phase 2 clinical trial for its lead candidate, OM002, in patients with irritable bowel syndrome by December 31, 2024?",0,0.9,True
"Will a U.S. federal court issue a final ruling that reinstates the 2016 pre-pandemic safety standards for the abortion drug mifepristone by December 31, 2025?",0,1.0,True
"Will Neuren Pharmaceuticals initiate a Phase 3 clinical trial of NNZ-2591 for the treatment of Pitt-Hopkins syndrome by June 30, 2025?",0,1.0,True
"Will Eli Lilly's Phase 3 trial of orforglipron (ATTAIN-1) meet its primary endpoint of weight reduction by December 31, 2025?",1,1.0,True
"Will Ferring Pharmaceuticals make Adstiladrin commercially available in the United States by December 31, 2023?",1,1.0,True
"Will the FDA approve AstraZeneca's supplemental biologics license application for perioperative durvalumab in resectable non-small cell lung cancer (NSCLC) by December 31, 2024?",1,1.0,True
"Will Astrazeneca's Phase 3 ADRIATIC trial for durvalumab in limited-stage small cell lung cancer meet its primary endpoint of overall survival by December 31, 2024?",1,1.0,True
"Will the FDA formally approve Emergent BioSolutions' Narcan nasal spray for over-the-counter use by March 31, 2023?",1,1.0,True
"Will Southern Star Research officially open its new regional offices in South Korea and Singapore by December 31, 2023?",1,0.9,True
"Will AstraZeneca's Phase 3 ADRIATIC trial results for durvalumab in limited-stage small-cell lung cancer be published in a peer-reviewed journal by December 31, 2024?",1,1.0,True
"Will the FDA approve AbbVie's tavapadon for the treatment of Parkinson's disease by December 31, 2025?",0,1.0,True
"Will Bayer's Finerenone receive FDA approval for the treatment of heart failure with preserved ejection fraction (HFpEF) by December 31, 2025?",1,1.0,True
"Will AstraZeneca complete its acquisition of Gracell Biotechnologies by March 31, 2024?",1,1.0,True
"Will the FDA grant traditional full approval to Eisai and Biogen's Alzheimer's drug Leqembi (lecanemab) by July 31, 2023?",1,1.0,True
"Will Aerie Pharmaceuticals' AR-15512 (COMET-2 trial) meet its primary endpoint for dry eye disease by December 31, 2024?",1,1.0,True
"Will Johnson & Johnson's nipocalimab receive FDA approval for the treatment of generalized myasthenia gravis by June 30, 2025?",1,1.0,True
"Will the FDA approve MDMA hydrochloride (MDMA HCl) for the treatment of PTSD by August 31, 2024?",0,1.0,True
"Will Argenx release data from its POTS trial of intravenous Vyvgart for post-Covid POTS by March 31, 2024?",0,1.0,True
"Will the FDA approve GSK's Nucala (mepolizumab) for the treatment of chronic obstructive pulmonary disease (COPD) by December 31, 2025?",1,1.0,True
"Will PTC Therapeutics release additional Phase 2 clinical data for its Huntington's disease drug candidate PTC518 by June 30, 2025?",1,1.0,True
"Will AstraZeneca's capivasertib Phase 3 CAPItello-290 trial in triple-negative breast cancer (TNBC) meet its primary endpoint by December 31, 2024?",0,1.0,True
"Will Ocular Therapeutix file a New Drug Application (NDA) for Axpaxli in wet age-related macular degeneration by December 31, 2024?",0,1.0,True
"Will the FDA grant full traditional approval to Eli Lilly's donanemab for the treatment of early Alzheimer's disease by July 31, 2024?",1,1.0,True
"Will the FDA approve Lykos Therapeutics' MDMA-assisted therapy for the treatment of post-traumatic stress disorder (PTSD) by August 11, 2024?",0,1.0,True
"Will NeuroSense Therapeutics initiate its Phase 3 clinical trial of PrimeC for the treatment of ALS by December 31, 2024?",0,1.0,True
"Will S.4071, the Helping Experts Accelerate Rare Treatments Act of 2022, be signed into law by December 31, 2022?",0,1.0,True
"Will scPharmaceuticals receive FDA supplemental approval for an expanded indication of Furoscix (furosemide injection) to include Class IV heart failure patients by December 31, 2024?",1,1.0,True
"Will the FDA approve Eli Lilly's donanemab for the treatment of early symptomatic Alzheimer's disease by December 31, 2024?",1,1.0,True
"Will Merck KGaA's Phase 3 clinical trial for evobrutinib in multiple sclerosis meet its primary endpoints by December 31, 2024?",0,1.0,True
"Will Alector's Phase 3 INFRONT-3 trial for latozinemab (AL001) in frontotemporal dementia meet its primary endpoint by December 31, 2025?",0,1.0,True
"Will Arcutis Biotherapeutics receive FDA approval for roflumilast cream (ZORYVE) for the treatment of scalp psoriasis by December 31, 2024?",0,1.0,True
"Will Recursion Pharmaceuticals report top-line data from its Phase 2 clinical trial of REC-4881 for familial adenomatous polyposis by June 30, 2025?",0,1.0,True
"Will Pfizer and BioNTech receive full FDA approval for a next-generation variant-adapted COVID-19 vaccine by December 31, 2024?",1,1.0,True
"Will Vanda Pharmaceuticals receive FDA approval for tasimelteon (Hetlioz) for the treatment of insomnia by December 31, 2024?",0,1.0,True
"Will Oramed Pharmaceuticals' oral GLP-1 candidate ORMD-0901 advance to a Phase 3 clinical trial by December 31, 2024?",0,1.0,True
"Will Boehringer Ingelheim's Phase 3 study of nerandomilast in progressive fibrosing interstitial lung diseases reach primary completion by December 31, 2024?",1,1.0,True
"Will the FDA approve Curium's 505(b)(2) New Drug Application for lutetium Lu 177 dotatate injection by July 31, 2025?",0,0.9,True
"Will Biogen and Eisai's Leqembi (lecanemab) receive traditional (non-accelerated) FDA approval for the treatment of Alzheimer’s disease by December 31, 2023?",1,1.0,True
"Will Fresenius Kabi's adalimumab biosimilar Idacio be commercially available in the United States by July 31, 2023?",1,1.0,True
"Will Biogen complete the confirmatory clinical trial for its Alzheimer’s drug Aduhelm by December 31, 2030?",0,1.0,True
"Will the FDA approve Ionis Pharmaceuticals' donidalorsen for the prophylactic treatment of hereditary angioedema (HAE) by December 31, 2025?",1,1.0,True
"Did the HEART-FID trial of ferric carboxymaltose (FCM) in patients with heart failure and iron deficiency meet its primary hierarchical endpoint with a p-value of less than 0.01 by August 31, 2023?",0,1.0,True
"Will Praxis Precision Medicines report positive top-line results from its Phase 2b clinical trial of PRAX-944 for the treatment of essential tremor by December 31, 2022?",0,1.0,True
"Will Novo Nordisk's Phase 3 ESSENCE trial for semaglutide in patients with non-alcoholic steatohepatitis (NASH) meet its primary endpoint by December 31, 2024?",1,1.0,True
Will Bluebird Bio's gene therapy lovotibeglogene autotemcel (lovo-cel) receive FDA approval for sickle cell disease by the end of 2024?,1,1.0,True
"Will the FDA approve pembrolizumab in combination with chemotherapy for the first-line treatment of advanced or recurrent endometrial carcinoma by December 31, 2025?",1,1.0,True
"Will Avidity Biosciences report efficacy data from the AOC 1001 Marina-OLE trial for myotonic dystrophy type 1 by June 30, 2024?",1,1.0,True
"Will the dqTACT (direct qPCR-based rapid T cell activation) assay receive FDA 510(k) clearance or De Novo marketing authorization for the assessment of SARS-CoV-2 cellular immunity by December 31, 2025?",0,0.9,True
"Will AstraZeneca's Phase 3 ADRIATIC trial for Imfinzi (durvalumab) meet its primary endpoint of overall survival in patients with limited-stage small-cell lung cancer by December 31, 2024?",1,1.0,True
"Will the Phase 3 rEECur clinical trial report results for the carboplatin plus etoposide treatment arm by December 31, 2026?",1,1.0,True
"Will the FDA grant approval to Moderna's mRNA flu vaccine (mRNA-1010) for the prevention of influenza by July 1, 2025?",0,1.0,True
"Will Health Canada approve Kamada's application to manufacture Cytogam by December 31, 2024?",1,1.0,True
"Will Eikon Therapeutics' Keynote-G04 Phase 2/3 trial of EIK1001 in combination with Keytruda meet its primary endpoint of Progression-Free Survival (PFS) by December 31, 2026?",0,1.0,True
"Will Moderna's mRNA flu vaccine receive FDA approval by December 31, 2025?",0,1.0,True
"Will Angion Biomedica announce a definitive merger, sale of assets, or other strategic business combination by June 30, 2023?",1,1.0,True
"Will Adaptimmune submit an Investigational New Drug (IND) application to the FDA for its PRAME cell therapy program by December 31, 2023?",0,1.0,True
"Will Biosplice Therapeutics announce the commencement of a new Phase 2 clinical trial for GZ-868 in osteoarthritis by December 31, 2025?",0,0.95,True
"Will the FDA approve Sanofi's tolebrutinib for the treatment of non-relapsing secondary progressive multiple sclerosis (nrSPMS) by December 31, 2025?",0,1.0,True
"Will the Phase 3 PROTEUS trial, evaluating apalutamide plus androgen deprivation therapy in localized prostate cancer, meet its primary endpoint of metastasis-free survival by December 31, 2025?",0,1.0,True
"Will Phathom Pharmaceuticals receive FDA approval for vonoprazan for the treatment of erosive esophagitis by December 31, 2023?",1,1.0,True
"Will Allakos report topline data from its Phase 2 clinical trials of lirentelimab for atopic dermatitis or chronic spontaneous urticaria by December 31, 2023?",0,1.0,True
"Will Vertex Pharmaceuticals and CRISPR Therapeutics' Casgevy receive European Commission approval for the treatment of transfusion-dependent beta thalassemia by December 31, 2024?",1,1.0,True
"Will the FDA approve Bristol Myers Squibb's KarXT (xanomeline-trospium) for the treatment of schizophrenia by September 26, 2024?",1,1.0,True
"Will Vedanta Biosciences' VE303 receive FDA approval for the prevention of recurrent Clostridioides difficile infection by December 31, 2026?",0,1.0,True
"Will Vir Biotechnology release topline data readouts for both its Hepatitis B and Hepatitis D programs by December 31, 2023?",0,0.9,True
"Will the FDA approve Vertex Pharmaceuticals' suzetrigine for pain management by January 30, 2025?",1,1.0,True
"Will Kronos Bio report results from its Phase I/II clinical trial of KB-0742 for relapsed or refractory solid tumors by December 31, 2023?",1,1.0,True
"Will Amgen's tarlatamab (Imdelltra) meet its primary endpoint of overall survival in the DeLLphi-304 Phase 3 clinical trial for small cell lung cancer by December 31, 2024?",1,1.0,True
Did the cariprazine 1.5 mg/d or 3 mg/d treatment groups achieve a statistically significant improvement over placebo in the MADRS total score primary endpoint in the Phase 3 trial NCT03739203?,0,0.9,True
"Will the FDA approve Biogen's tofersen (QALSODY) for the treatment of SOD1-ALS by January 31, 2023?",0,1.0,True
"Will a final court ruling in the Alliance for Hippocratic Medicine v. FDA case revoke the FDA's approval of Danco's mifepristone by December 31, 2024?",0,1.0,True
"Did AM-Pharma's Phase 3 REVIVAL trial of ilofotase alfa meet its primary endpoint of reducing 28-day all-cause mortality by December 31, 2022?",0,1.0,True
"Will Eli Lilly's Phase 3 MONARCH 3 trial demonstrate a statistically significant improvement in Overall Survival (OS) for abemaciclib in the final analysis by December 31, 2023?",0,1.0,True
"Will EIP Pharma's neflamapimod meet its primary endpoint in a Phase 2b clinical trial for mild-to-moderate dementia with Lewy bodies (DLB) by December 31, 2025?",1,0.9,True
"Will Citius Pharmaceuticals' receive FDA approval for its antibiotic lock solution Mino-Lok by June 30, 2025?",0,1.0,True
"Will Biogen and Eisai's Leqembi receive marketing authorization from the European Medicines Agency (EMA) by December 31, 2024?",0,1.0,True
"Will Agios Pharmaceuticals' mitapivat (Pyrukynd) receive FDA approval for the treatment of sickle cell disease by December 31, 2025?",0,1.0,True
"Will CMS (Centers for Medicare & Medicaid Services) issue a final decision to cover Biogen's Aduhelm only for patients in clinical trials by April 30, 2022?",1,1.0,True
Will Pfizer's ongoing clinical trials for its pipeline oncology agents achieve primary endpoint significance for solid tumor indications as reported in ESMO Congress updates by the end of 2025?,1,0.9,True
"Will HI-Bio initiate a Phase 3 registrational trial for felzartamab in patients with primary membranous nephropathy (PMN) by June 30, 2024?",0,1.0,True
"Will Avantium officially open its FDCA Flagship Plant by October 31, 2024?",1,1.0,True
"Will the FDA approve Mirati Therapeutics' adagrasib for the treatment of KRASG12C-mutated non-small cell lung cancer by December 31, 2022?",1,1.0,True
"Will ImmunoGen's Phase 3 MIRASOL trial of Elahere in platinum-resistant ovarian cancer meet its primary endpoint of progression-free survival by June 30, 2023?",1,1.0,True
"Will the FDA approve Sandoz's denosumab biosimilar (prescribed for osteoporosis and bone metastases) by June 30, 2024?",1,1.0,True
"Will Vanda Pharmaceuticals submit a New Drug Application (NDA) for tradipitant for the prevention of motion-induced vomiting to the FDA by December 31, 2024?",0,0.95,True
"Will Journey Medical's Emrosi (minocycline) receive FDA approval for the treatment of inflammatory lesions of rosacea by November 30, 2024?",1,1.0,True
"Will the FDA approve MAPS Public Benefit Corporation's MDMA-assisted therapy for the treatment of PTSD by December 31, 2024?",0,1.0,True
"Will Alnylam Pharmaceuticals report that its Phase 3 HELIOS-B trial of vutrisiran met its primary endpoint in patients with ATTR amyloidosis with cardiomyopathy by June 30, 2024?",1,1.0,True
"Will Roche present full Phase 1 data for its obesity drug candidates CT-388 and CT-996 at the European Association for the Study of Diabetes (EASD) meeting by September 13, 2024?",1,1.0,True
"Will the FDA approve Boehringer Ingelheim's spesolimab (Spevigo) for the prevention of generalized pustular psoriasis (GPP) flares by March 31, 2024?",1,1.0,True
"Will ClostraBio initiate a Phase 1a/b clinical study for CLB-004 in patients with ulcerative colitis by December 31, 2024?",0,0.9,True
"Will Sage Therapeutics' Zuranolone (Zurzuvae) receive marketing authorization from the European Medicines Agency (EMA) by June 30, 2025?",0,1.0,True
"Will Biogen and Eisai announce the completion and primary endpoint results of the Aduhelm confirmatory trial by December 31, 2026?",0,1.0,True
"Will the FDA approve Anavex Life Sciences' blarcamesine (ANAVEX 2-73) for the treatment of Rett syndrome by December 31, 2025?",0,0.9,True
"Will the Endotronix Cordella Heart Failure System receive FDA Pre-Market Approval (PMA) by June 30, 2024?",1,1.0,True
"Will the FDA approve Aldeyra Therapeutics' eye drop reproxalap for the treatment of dry eye disease by December 31, 2023?",0,1.0,True
"Will the European Medicines Agency (EMA) grant marketing authorization for Krystal Biotech's Vyjuvek (beremagene geperpavec) for the treatment of dystrophic epidermolysis bullosa by December 31, 2024?",0,1.0,True
"Will the FDA approve Lexicon Pharmaceuticals' Zynquista (sotagliflozin) for adults with type 1 diabetes and chronic kidney disease by December 31, 2024?",0,1.0,True
"Will Agios Pharmaceuticals' Phase III ENERGIZE-T trial (NCT04770779) for mitapivat meet its primary endpoint by December 31, 2024?",1,1.0,True
"Will the FDA approve Day One Biopharmaceuticals' tovorafenib for the treatment of pediatric low-grade glioma by June 30, 2024?",1,1.0,True
"Will the ASPro-PD Phase 3 trial of ambroxol for Parkinson's disease report its primary endpoint results by June 30, 2026?",0,1.0,True
"Will the FDA approve Bristol Myers Squibb's iberdomide for the treatment of relapsed or refractory multiple myeloma by March 31, 2026?",0,1.0,True
"Will Aulos Bioscience report positive topline Phase 2 data for AU-007 in patients with solid tumors by December 31, 2025?",1,1.0,True
"Will the FDA approve Galderma's nemolizumab for the treatment of moderate to severe atopic dermatitis by December 31, 2024?",1,1.0,True
"Will Adverum Biotechnologies announce preliminary efficacy and safety data from the Phase 2 LUNA trial of Ixo-vec for wet AMD by December 31, 2023?",1,1.0,True
"Will KGK Science Inc. publish results from a new N-of-1 clinical trial for a dietary supplement in a peer-reviewed journal by December 31, 2025?",0,0.9,True
"Will the FDA grant traditional full approval to Eisai and Biogen's Leqembi (lecanemab) for the treatment of early Alzheimer's disease by July 31, 2023?",1,1.0,True
"Will Novo Nordisk's CagriSema Phase 3 trial (REDEFINE 1) for weight management meet its primary endpoint of superior weight loss compared to semaglutide alone by December 31, 2024?",1,1.0,True
"Will Annovis Bio's Phase 3 clinical trial for buntanetap in Parkinson's disease meet its primary endpoints by December 31, 2024?",1,1.0,True
"Will Milestone Pharmaceuticals initiate a Phase 3 clinical trial of etripamil for the treatment of atrial fibrillation with rapid ventricular rate (AFib-RVR) by December 31, 2024?",0,0.9,True
"Will the National Institute on Drug Abuse (NIDA) issue its planned $2 million in grant awards for psychedelic-based SUD treatment research by September 30, 2025?",1,0.9,True
"Will the U.S. government finalize the proposed rule to require Medicare coverage for obesity drugs like Lilly's Zepbound by December 31, 2025?",0,1.0,True
"Will Insilico Medicine's Phase IIa clinical trial of ISM001-055 for idiopathic pulmonary fibrosis (NCT05975983) complete primary data collection in the U.S. by December 31, 2025?",0,1.0,True
"Will Eli Lilly's Olumiant (baricitinib) receive FDA approval for the treatment of atopic dermatitis in pediatric patients (ages 2-17) by December 31, 2023?",0,1.0,True
"Will Regeneron Pharmaceuticals receive FDA approval for a high-dose aflibercept (8 mg) formulation for the treatment of Diabetic Macular Edema by March 31, 2024?",1,1.0,True
"Will the FDA issue a permanent injunction against Calroy Health Sciences, LLC for the sale of unapproved cardiovascular drugs by December 31, 2025?",0,1.0,True
"Will Travere Therapeutics submit a supplemental New Drug Application (sNDA) to the FDA for sparsentan in the treatment of focal segmental glomerulosclerosis (FSGS) by December 31, 2023?",0,1.0,True
"Will the FDA approve Neurocrine Biosciences' valbenazine for the treatment of chorea associated with Huntington’s disease by August 20, 2023?",1,1.0,True
"Will the FDA approve Karuna Therapeutics' KarXT for the treatment of schizophrenia in adults by September 26, 2024?",1,1.0,True
"Will AstraZeneca's Phase 3 ADRIATIC trial results lead to FDA approval of Imfinzi for limited-stage small cell lung cancer by December 31, 2024?",1,1.0,True
"Will Aucentra Therapeutics complete its Phase 2 clinical trial of Auceliciclib by December 31, 2025?",1,1.0,True
"Will Roche's Phase 3 trial of tiragolumab in non-small cell lung cancer (SKYSCRAPER-01) meet its co-primary endpoint of overall survival by December 31, 2024?",0,1.0,True
"Will the FDA approve Madrigal Pharmaceuticals' resmetirom for the treatment of NASH by March 14, 2024?",1,1.0,True
"Will Capricor Therapeutics announce topline data from Cohort A of the Phase 3 HOPE-3 trial for CAP-1002 in Duchenne muscular dystrophy by December 31, 2024?",0,1.0,True
"Will the FDA approve Eli Lilly's tirzepatide for the treatment of moderate-to-severe obstructive sleep apnea (OSA) by June 30, 2025?",1,1.0,True
"Will the FDA approve Provention Bio's teplizumab for the treatment of type I diabetes by its PDUFA date of July 1, 2022?",0,1.0,True
"Will the Phase 3 TROPION-Breast01 trial (NCT05104866) meet its dual primary endpoint of overall survival (OS) with statistical significance by December 31, 2025?",0,1.0,True
"Will the REDUCE-AMI clinical trial (NCT03274700) report meeting its primary composite endpoint of all-cause death or new myocardial infarction by December 31, 2024?",0,1.0,True
"Will Eli Lilly's Phase 3 trial for Orforglipron (ACHIEVE-1) in adults with obesity meet its primary endpoints by December 31, 2025?",1,1.0,True
"Will AstraZeneca's datopotamab deruxtecan (Dato-DXd) receive FDA approval for the treatment of HR-positive/HER2-low breast cancer by December 31, 2024?",0,1.0,True
"Will MaaT Pharma's MaaT013 Phase 3 trial for the treatment of Graft-versus-host disease (GvHD) meet its primary endpoint by December 31, 2025?",1,1.0,True
"Will Eli Lilly's Phase 3 TRAILBLAZER-ALZ 2 trial for donanemab meet its primary endpoint by June 30, 2023?",1,1.0,True
"Will Fulcrum Therapeutics receive FDA approval for losmapimod for the treatment of FSHD by December 31, 2025?",0,1.0,True
"Will the EXCITE-HT sub-analysis study comparing esaxerenone versus trichlormethiazide for the treatment of Japanese patients with hypertension be published in a peer-reviewed journal by December 31, 2025?",1,1.0,True
"Will AstraZeneca's AMPLIFY Phase 3 trial of Calquence meet its primary endpoints in first-line chronic lymphocytic leukaemia by December 31, 2024?",1,1.0,True
"Will Exscientia initiate its Phase 1 healthy volunteer study of the LSD1 inhibitor EXS74539 by June 30, 2024?",0,0.9,True
"Will Perrigo's over-the-counter birth control pill Opill be available for purchase at major retail pharmacies in the United States by March 31, 2024?",1,1.0,True
"Will Pfizer and Astellas Pharma's EMBARK trial of enzalutamide (Xtandi) demonstrate a statistically significant improvement in overall survival compared to leuprolide alone by December 31, 2026?",1,1.0,True
"Will Eli Lilly receive FDA approval for tirzepatide for the treatment of obstructive sleep apnea by December 31, 2024?",1,1.0,True
"Will the U.S. Supreme Court issue a ruling that maintains the FDA’s 2000 approval of mifepristone by June 30, 2024?",1,1.0,True
"Will the FDA issue a final guidance or rule establishing an enhanced systematic process for the post-market assessment of chemicals in food by December 31, 2025?",0,1.0,True
"Will the FDA approve AbbVie and Genmab's epcoritamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) by July 31, 2023?",1,1.0,True
"Will the FDA grant approval for Autolus Therapeutics' obecabtagene autoleucel (obex-cel) for the treatment of adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia by December 31, 2024?",1,1.0,True
"Will the European Union's Joint Clinical Assessment (JCA) process for health technology assessments begin its implementation by January 31, 2025?",1,1.0,True
"Will aTyr Pharma release top-line data from the EFZO-FIT Phase 3 trial of efzofitimod by September 30, 2025?",1,1.0,True
"Will the U.S. Preventive Services Task Force (USPSTF) include Guardant Health's Shield blood test in its final recommendation guidelines for colorectal cancer screening by December 31, 2025?",0,1.0,True
"Will a federal court order the FDA to withdraw or suspend the approval of mifepristone (Mifeprex) by December 31, 2023?",0,1.0,True
"Will Viking Therapeutics receive FDA approval for VK2735 to enter Phase 3 clinical trials for the treatment of obesity by December 31, 2024?",0,1.0,True
"Will the FDA approve Marinus Pharmaceuticals' intravenous ganaxolone for the treatment of refractory status epilepticus by December 31, 2025?",0,1.0,True
"Will the FDA grant traditional approval to Eli Lilly's donanemab for the treatment of Alzheimer's disease by July 31, 2024?",1,1.0,True
"Will the FDA grant expanded approval for Novo Nordisk's semaglutide (Wegovy) to include the reduction of major adverse cardiovascular events in pediatric patients by December 31, 2024?",0,1.0,True
"Will the FDA approve Lykos Therapeutics' MDMA-assisted therapy for the treatment of post-traumatic stress disorder (PTSD) by August 31, 2024?",0,1.0,True
"Will Sensorion's SENS-401 meet its primary endpoint in the Phase IIa cochlear implantation trial (NCT05258773) by December 31, 2023?",0,1.0,True
"Will Kodiak Sciences advance KSI-501 into a Phase 2 clinical trial for diabetic macular edema by December 31, 2024?",0,1.0,True
"Will Axsome Therapeutics announce the completion of its Phase 3 clinical trial for Auvelity in Alzheimer's disease agitation by June 30, 2024?",1,1.0,True
"Will Stemline Therapeutics receive Phase 3 trial results for elacestrant in combination with abemaciclib for metastatic breast cancer by December 31, 2024?",0,1.0,True
"Will The Lancet retract the 2009 article reporting the results of the RECORD4 trial of rivaroxaban by December 31, 2025?",0,0.9,True
"Will Adaptimmune's uza-cel (ADP-A2M4CD8) receive FDA approval for the treatment of esophageal cancer by December 31, 2026?",0,1.0,True
"Will Theranexus complete the treatment phase of its Phase I/II trial for Batten-1 in juvenile Batten disease (CLN3) by June 30, 2025?",1,1.0,True
"Will the FDA approve Galderma's nemolizumab for the treatment of atopic dermatitis by December 31, 2024?",1,0.9,True
"Will the FDA approve Karuna Therapeutics' KarXT (xanomeline-trospium) for the treatment of schizophrenia by September 26, 2024?",1,1.0,True
"Will the FDA approve Dechra Veterinary Products' methimazole oral solution for the treatment of hyperthyroidism in cats by December 31, 2024?",0,0.9,True
"Will the FDA grant a new or reinstated approval for TG Therapeutics' umbralisib (Ukoniq) for any hematologic malignancy by December 31, 2025?",0,1.0,True
"Will Novo Nordisk publish the full results of the FLOW phase 3 trial for Ozempic in chronic kidney disease by June 30, 2024?",1,1.0,True
"Will the FDA approve Johnson & Johnson's nipocalimab for the treatment of generalized myasthenia gravis (gMG) by December 31, 2025?",1,1.0,True
"Will the FDA grant marketing authorization to Futura Medical's MED3000 topical gel for over-the-counter erectile dysfunction treatment by December 31, 2023?",1,1.0,True
"Will Janssen advance its oral IL-23 receptor antagonist JNJ-2113 to Phase III clinical trials for moderate-to-severe plaque psoriasis by June 30, 2024?",1,1.0,True
"Will Summit Therapeutics announce that the HARMONi-2 Phase 3 trial met its primary endpoint of progression-free survival by December 31, 2024?",1,1.0,True
"Will Eli Lilly's Verzenio (abemaciclib) receive FDA approval for an expanded indication in early breast cancer treatment by December 31, 2024?",1,1.0,True
"Will Mersana Therapeutics initiate the dose expansion portion of its Phase 1 clinical trial for XMT-1660 by December 31, 2024?",1,1.0,True
"Will Agios Pharmaceuticals receive FDA approval for mitapivat in the treatment of thalassemia by December 31, 2026?",1,1.0,True
"Will Nicox report that its Phase 3 trial for NCX 470 (Denali trial) met its primary endpoint by June 30, 2025?",0,1.0,True
"Will the FDA approve Genfit and Ipsen's elafibranor for the treatment of primary biliary cholangitis (PBC) by December 31, 2024?",1,1.0,True
Will the U.S. Supreme Court uphold the FDA's current authorization of mifepristone following its review of the case in 2024?,1,1.0,True
"Will Sanofi and ABL Bio's ABL301 complete its Phase 1 clinical trial for Parkinson’s disease by December 31, 2025?",1,1.0,True
"Will Agepha Pharma receive FDA approval for a new indication of Lodoco (colchicine) for pediatric cardiovascular use by December 31, 2025?",0,1.0,True
"Will Clinuvel Pharmaceuticals announce that its Phase 3 CUV105 clinical trial of afamelanotide for vitiligo met its primary endpoint by June 30, 2025?",0,1.0,True
"Will MEI Pharma and Kyowa Kirin receive FDA approval for zandelisib for the treatment of B-cell malignancies by December 31, 2025?",0,1.0,True
"Will Janssen's MARIPOSA trial demonstrate a statistically significant improvement in overall survival (OS) for Lazcluze plus Rybrevant compared to Tagrisso by December 31, 2025?",1,1.0,True
"Will the FDA issue a final regulatory decision to further restrict the distribution of Mifeprex (mifepristone) by December 31, 2024?",0,1.0,True
"Will a federal court order the FDA to withdraw or suspend the approval of mifepristone (Mifeprex) by December 31, 2023?",0,1.0,True
"Will the FDA grant approval to Eli Lilly's donanemab for the treatment of early-stage Alzheimer's disease by June 30, 2024?",0,1.0,True
"Will Janssen's esketamine (Spravato) nasal spray receive FDA approval for a new supplemental indication in the treatment of major depressive disorder by December 31, 2025?",1,1.0,True
"Will Eli Lilly's donanemab (Kisunla) receive marketing authorization from the European Medicines Agency (EMA) by December 31, 2024?",0,1.0,True
"Will Vistagen Pharmaceuticals receive FDA approval for fasedienol (PH94B) nasal spray for the treatment of social anxiety disorder by December 31, 2025?",0,1.0,True
"Will Arthrosi Therapeutics announce the official commencement of dosing in a global Phase 3 clinical trial for AR882 by December 31, 2024?",1,1.0,True
"Will the FDA approve Merck's clesrovimab (MK-1654) for the prevention of RSV in infants by December 31, 2025?",1,1.0,True
"Will atai Life Sciences announce topline results from its Phase 1 bridging study of subcutaneous PCN-101 by December 31, 2023?",1,1.0,True
"Will Novo Nordisk submit a regulatory application for semaglutide (Wegovy) for the treatment of MASH to the FDA by June 30, 2025?",1,1.0,True
"Will the FDA authorize Moderna's fourth dose of its COVID-19 vaccine for all adults by June 30, 2022?",0,1.0,True
"Will the FDA grant traditional full approval to Eisai and Biogen's Leqembi (lecanemab) for the treatment of Alzheimer’s disease by July 31, 2023?",1,1.0,True
"Will Astellas Pharma's (Iveric Bio) IZERVAY receive European Commission approval for the treatment of geographic atrophy by December 31, 2024?",0,0.9,True
"Will Exelixis's total research and development (R&D) expenses for the fiscal year ending December 31, 2023, exceed $1.0 billion as reported in its annual financial results?",1,1.0,True
"Will the FDA approve Merck's pembrolizumab (Keytruda) as a first-line treatment for advanced or recurrent endometrial cancer by December 31, 2024?",1,1.0,True
"Will Karuna Therapeutics' KarXT (xanomeline-trospium) receive FDA approval for the treatment of schizophrenia by September 26, 2024?",1,1.0,True
"Will the FDA approve Pfizer's RSV vaccine for adults aged 60 and older by May 31, 2023?",1,1.0,True
"Will AstraZeneca's Phase 3 trial for datopotamab deruxtecan in non-small cell lung cancer meet its primary endpoint of overall survival by December 31, 2024?",0,1.0,True
"Will Prometheus Biosciences initiate Phase 3 pivotal trials for PRA023 in patients with ulcerative colitis by December 31, 2023?",1,1.0,True
"Will Florida's Agency for Health Care Administration notify the FDA of its first shipment of imported drugs from Canada by December 31, 2024?",0,1.0,True
"Will the FDA approve Moderna's RSV vaccine (mRNA-1345) for adults aged 60 and older by June 30, 2024?",1,1.0,True
"Will Futura Medical's MED3000 receive FDA marketing authorization for over-the-counter use by March 31, 2023?",0,1.0,True
"Will Ultragenyx Pharmaceutical report results from the KIK-AS Phase 1/2 trial expansion cohort of GTX-102 by June 30, 2024?",1,1.0,True
"Will Menarini Group's Orserdu (elacestrant) receive FDA approval for an expanded indication in the adjuvant setting for breast cancer by December 31, 2025?",0,1.0,True
"Will the atezolizumab and isatuximab experimental arm of the MORPHEUS-CRC Phase Ib/II trial (NCT03555149) meet its primary endpoint of objective response rate by December 31, 2022?",0,1.0,True
"Will Vaxcyte initiate its Phase 3 clinical trial for the VAX-31 pneumococcal conjugate vaccine by June 30, 2025?",0,1.0,True
"Will Throne Biotechnologies' Stem Cell Educator therapy receive FDA Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of Type 1 Diabetes by December 31, 2025?",1,1.0,True
"Will PTC Therapeutics receive FDA approval for sepiapterin to treat phenylketonuria (PKU) by December 31, 2024?",0,1.0,True
"Will DiscGenics enroll the first patient in its PIVOT (DGX-A02) Phase 3 clinical trial for rebonuputemcel by December 31, 2024?",0,1.0,True
"Will Bristol Myers Squibb and Janssen initiate a Phase 3 clinical trial for milvexian by December 31, 2022?",0,1.0,True
"Will Atara Biotherapeutics receive FDA approval for tabelecleucel (tab-cel) by December 31, 2025?",0,1.0,True
"Will 4Moving Biotech report final data from its Phase 1 trial (NCT05419856) of 4P004 for knee osteoarthritis by March 31, 2024?",0,1.0,True
"Will Axsome Therapeutics announce positive results for its Phase 3 ADVANCE-2 trial of AXS-05 (Auvelity) in Alzheimer’s disease agitation by December 31, 2024?",0,1.0,True
"Will Boehringer Ingelheim's zongertinib (BI 1810631) receive FDA approval for the treatment of HER2-mutated non-small cell lung cancer by December 31, 2026?",1,1.0,True
"Will Agepha Pharma receive FDA approval for a new indication of Lodoco (colchicine) for pediatric cardiovascular use by December 31, 2025?",0,1.0,True
"Will the FDA approve AbbVie's Skyrizi (risankizumab) for the treatment of adults with active psoriatic arthritis by January 31, 2022?",1,1.0,True
"Will Immunome submit a New Drug Application (NDA) to the FDA for AL102 in desmoid tumors by December 31, 2025?",0,1.0,True
"Will the final overall survival analysis results for the PEACE-3 trial (EORTC-1333-GUCG) be published or publicly presented by December 31, 2026?",0,0.9,True
"Will Seagen's tucatinib receive FDA approval for the treatment of HER2-positive metastatic colorectal cancer by December 31, 2024?",1,1.0,True
"Will Catalyst Pharmaceuticals' drug Firdapse (amifampridine) maintain its orphan drug exclusivity through November 30, 2025?",0,1.0,True
"Will the FDA grant accelerated approval to Eisai and Biogen's Alzheimer's drug lecanemab by January 6, 2023?",1,1.0,True
"Will Teva Pharmaceutical launch its once-daily Austedo XR formulation in the United States by June 30, 2023?",1,0.9,True
"Will the European Medicines Agency (EMA) approve Astellas Pharma's IZERVAY (avacincaptad pegol) for the treatment of geographic atrophy by December 31, 2024?",0,1.0,True
"Will Guard Therapeutics' RMC-035 meet its primary endpoint of preventing acute kidney injury in the Phase 2 AKITA trial by December 31, 2023?",0,1.0,True
"Will Arthrosi Therapeutics initiate a Phase 3 clinical trial for AR882 in patients with gout by December 31, 2025?",1,1.0,True
"Will the FDA grant full traditional approval to Eli Lilly's donanemab for the treatment of early Alzheimer's disease by July 31, 2024?",1,1.0,True
"Will Idorsia's hypertension medication Tryvio (aprocitentan) be commercially available in the United States by December 31, 2024?",1,1.0,True
"Will AbbVie's risankizumab (Skyrizi) receive FDA approval for the treatment of moderately to severely active ulcerative colitis by December 31, 2024?",1,1.0,True
"Will the FDA grant traditional approval to Eisai and Biogen's Alzheimer's drug lecanemab (Leqembi) by July 31, 2023?",1,1.0,True
"Will Orasis Pharmaceuticals' QLOSI (pilocarpine hydrochloride ophthalmic solution) be commercially available in the United States by June 30, 2024?",0,1.0,True
"Will Merck KGaA's EVOLUTION Phase 3 clinical trial program for evobrutinib meet its primary endpoints by December 31, 2023?",0,1.0,True
"Will Viking Therapeutics' Phase 2 VENTURE trial for VK2735 demonstrate a statistically significant mean percentage reduction in body weight compared to placebo by December 31, 2024?",1,1.0,True
"Will the FDA approve Bayer's Aliqopa (copanlisib) in combination with Rituxan for the treatment of indolent non-Hodgkin lymphoma by December 31, 2024?",0,1.0,True
"Will Alnylam Pharmaceuticals receive FDA approval for vutrisiran (Amvuttra) for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM) by June 30, 2025?",1,1.0,True
"Will Eli Lilly's SURMOUNT-5 Phase 3 head-to-head trial of tirzepatide vs semaglutide meet its primary endpoint of superior weight loss by December 31, 2024?",1,1.0,True
"Will Aura Biosciences initiate a Phase 2 clinical trial for bel-sar in patients with non-muscle invasive bladder cancer by December 31, 2025?",1,1.0,True
"Will Reva Medical's MOTIV IDE global randomized controlled trial for the Motiv scaffold complete its primary enrollment of 292 patients by December 31, 2025?",1,1.0,True
"Will the FDA approve Soleno Therapeutics' diazoxide choline extended-release (DCCR) for the treatment of Prader-Willi syndrome by March 27, 2025?",1,1.0,True
"Will the FDA grant full approval to a COVID-19 vaccine for children under 5 years old by December 31, 2022?",0,1.0,True
"Will the FDA approve Regeneron's 8 mg aflibercept for the treatment of diabetic macular edema (DME) by August 31, 2023?",1,1.0,True
"Will Esperion Therapeutics receive FDA approval for a further label expansion of bempedoic acid to include pediatric patients by December 31, 2025?",0,1.0,True
"Will the FDA approve Novocure's Premarket Approval (PMA) application for Tumor Treating Fields (TTFields) in non-small cell lung cancer (NSCLC) by December 31, 2024?",1,1.0,True
"Will Cadence OTC begin late-stage clinical trials for its combined oral contraceptive pill by December 31, 2024?",0,0.9,True
"Will HistoSonics receive FDA clearance for an expanded clinical indication of the Edison System specifically for kidney tumors by December 31, 2024?",0,1.0,True
"Will Biogen and Eisai's subcutaneous version of Leqembi (lecanemab) receive FDA approval for the treatment of Alzheimer's disease by March 31, 2025?",0,1.0,True
"Will the FDA grant full traditional approval to Eisai and Biogen's lecanemab for the treatment of Alzheimer’s disease by September 30, 2023?",1,1.0,True
"Will BlueRock Therapeutics begin enrolling patients in its Phase 2 study of bemdaneprocel for Parkinson’s disease by June 30, 2024?",0,0.95,True
"Will the FDA grant traditional approval to Eli Lilly's donanemab for the treatment of early symptomatic Alzheimer's disease by December 31, 2024?",1,1.0,True
"Will Moderna's RSV vaccine candidate mRNA-1345 receive FDA approval for the prevention of RSV in older adults by June 30, 2024?",1,1.0,True
"Will Amgen and AstraZeneca receive FDA approval for the Tezspire (tezepelumab) self-administered pre-filled pen for pediatric patients aged 6 to 11 by December 31, 2024?",0,1.0,True
"Will Medtronic's ADAPT-PD pivotal trial (NCT04547712) for adaptive deep brain stimulation (aDBS) meet its primary endpoints by December 31, 2025?",1,1.0,True
"Will AstraZeneca's DUO-O Phase 3 trial report a statistically significant improvement in overall survival (OS) for the durvalumab plus olaparib arm by December 31, 2025?",0,1.0,True
"Will Organon and Henlius receive FDA approval for their denosumab biosimilar (HLX14) for the treatment of osteoporosis and bone metastases by December 31, 2024?",0,1.0,True
"Will Health Canada approve Eisai and Biogen's lecanemab for the treatment of early Alzheimer's disease by June 30, 2024?",0,1.0,True
"Will NewAmsterdam Pharma's obicetrapib-ezetimibe combination therapy (TANDEM trial) receive FDA approval for LDL cholesterol reduction by December 31, 2025?",0,1.0,True
"Will Viking Therapeutics' Phase 3 trial for VK2809 in patients with NASH meet its primary endpoint of reduction in liver fat by December 31, 2024?",0,1.0,True
"Will the FDA approve Madrigal Pharmaceuticals' resmetirom for the treatment of non-alcoholic steatohepatitis (NASH) by March 14, 2024?",1,1.0,True
"Will Biogen's Aduhelm (aducanumab) receive full FDA approval, converted from accelerated approval, by December 31, 2024?",0,1.0,True
"Will Genentech's inavolisib receive FDA approval for the treatment of PIK3CA-mutant advanced breast cancer in the first-line setting by December 31, 2024?",1,1.0,True
"Will Ionis Pharmaceuticals report top-line data from its Phase 1/2a clinical trial of ION582 (IONIS-HALOS-2.5Rx) for Angelman syndrome by December 31, 2024?",1,1.0,True
"Will SIFI's polihexanide (Akantior) receive FDA approval for the treatment of fungal keratitis by December 31, 2025?",0,0.9,True
"Will Biomind Labs receive FDA Breakthrough Therapy Designation for BMND08 for the treatment of depression and anxiety in Alzheimer's disease by December 31, 2025?",0,1.0,True
"Will Nektar Therapeutics complete its Phase 2/3 trial of the IL-15 receptor agonist NKTR-255 (NCT05664217) by December 31, 2025?",1,1.0,True
"Will Oramed Pharmaceuticals' oral insulin candidate ORMD-0801 receive FDA approval for the treatment of Type 2 Diabetes by December 31, 2025?",0,1.0,True
"Will Takeda Pharmaceutical's soticlestat receive FDA approval for the treatment of Dravet syndrome or Lennox-Gastaut syndrome by December 31, 2026?",0,1.0,True
"Will Genentech's inavolisib (Itovebi) receive European Commission marketing authorization for HR-positive, HER2-negative advanced breast cancer by June 30, 2025?",0,1.0,True
"Will Applied Therapeutics receive FDA approval for govorestat to treat classic galactosemia by December 31, 2025?",0,1.0,True
"Will Karuna Therapeutics' KarXT receive FDA approval for the treatment of schizophrenia by September 26, 2024?",1,1.0,True
"Will the FDA approve AbbVie's upadacitinib (Rinvoq) for the treatment of moderately to severely active Crohn's disease by June 30, 2023?",1,1.0,True
"Will Vertex Pharmaceuticals and CRISPR Therapeutics receive FDA approval for exagamglogene autotemcel (exa-cel) for the treatment of transfusion-dependent beta-thalassemia by March 31, 2024?",1,1.0,True
"Will the Phase 2 OCLURANDOM trial of 177Lu-DOTA-TATE (lutetium-octreotate) meet its primary endpoint of significantly improving progression-free survival compared to sunitinib by September 30, 2022?",1,1.0,True
"Will Sandoz or Teva Pharmaceuticals receive FDA approval for a generic version of semaglutide (Ozempic/Wegovy) by December 31, 2025?",0,1.0,True
"Will Ironwood Pharmaceuticals receive FDA approval for apraglutide for the treatment of Short Bowel Syndrome (SBS) by June 30, 2025?",0,1.0,True
"Will the FDA approve Bristol Myers Squibb's KarXT (xanomeline-trospium) for the treatment of schizophrenia by September 26, 2024?",1,1.0,True
"Will Biogen's investigational ALS drug BIIB105 advance to Phase 3 clinical trials by December 31, 2025?",0,1.0,True
"Will Vera Therapeutics initiate its pivotal Phase 3 clinical trial of atacicept for the treatment of IgA nephropathy by June 30, 2023?",1,1.0,True
"Will Paradigm Biopharmaceuticals receive Provisional Approval from the Australian Therapeutic Goods Administration (TGA) for injectable pentosan polysulfate sodium (iPPS) by December 31, 2025?",0,1.0,True
"Will Boehringer Ingelheim announce the initiation of a Phase 3 clinical trial for survodutide in patients with MASH by December 31, 2024?",1,1.0,True
"Will Sanofi and AstraZeneca receive FDA expanded approval for Beyfortus (nirsevimab) for use in all infants during their first RSV season by December 31, 2024?",1,1.0,True
"Will a federal court order the FDA to withdraw its approval of mifepristone by December 31, 2023?",0,1.0,True
"Will Eli Lilly's Phase 3 SUMMIT trial for tirzepatide in patients with heart failure with preserved ejection fraction (HFpEF) and obesity meet its primary endpoints by December 31, 2024?",1,1.0,True
"Will Harm Reduction Therapeutics' over-the-counter naloxone nasal spray, RiVive, be commercially available for purchase by March 31, 2024?",1,0.95,True
"Will the FDA approve Sanofi's supplemental Biologics License Application (sBLA) for ALTUVIIIO for the treatment of children with hemophilia A by June 30, 2024?",1,1.0,True
"Will Gilead Sciences submit a New Drug Application (NDA) to the FDA for lenacapavir for HIV prevention (PrEP) by June 30, 2025?",1,1.0,True
"Will Agios Pharmaceuticals receive FDA approval for mitapivat (Pyrukynd) to treat adults with thalassemia by December 31, 2025?",1,1.0,True
"Will the FDA finalize its guidance on 'Integrating Randomized Controlled Trials for Drug and Biological Products Into Routine Clinical Practice' by December 31, 2025?",0,0.9,True
"Will GSK submit a regulatory filing to the FDA for the re-approval of Blenrep (belantamab mafodotin) for the treatment of multiple myeloma by December 31, 2024?",1,1.0,True
"Will AbbVie submit a New Drug Application (NDA) to the FDA for tavapadon for the treatment of Parkinson's disease by December 31, 2025?",1,1.0,True
"Will BioLineRx or its partner Cellectar Biosciences submit a New Drug Application (NDA) to the FDA for iopofosine I-131 in Waldenström macroglobulinemia by December 31, 2024?",0,1.0,True
"Will Cytokinetics' aficamten meet its primary endpoint in the SEQUOIA-HCM Phase 3 trial by December 31, 2023?",1,1.0,True
"Will Madrigal Pharmaceuticals announce that its second Phase 3 trial of resmetirom for NASH met its primary endpoints by December 31, 2022?",0,1.0,True
"Will Novo Nordisk's semaglutide receive FDA approval for the treatment of obstructive sleep apnea by December 31, 2025?",0,1.0,True
"Will Alnylam Pharmaceuticals' subcutaneous zilebesiran meet its primary endpoint in the Phase 2 KARDIA-2 trial for hypertension by December 31, 2024?",1,1.0,True
"Will the FDA issue a final rule or administrative order to revoke the authorization of Red Dye No. 3 for use in food products by December 31, 2025?",1,1.0,True
"Will Iveric Bio submit a New Drug Application (NDA) for avacincaptad pegol (Zimura) to the FDA by March 31, 2023?",1,1.0,True
"Will the Phase 3 NRG-GI006 (GIANT) trial comparing proton beam therapy to intensity-modulated radiation therapy for esophageal cancer report primary endpoint data achieving statistical significance by December 31, 2025?",0,1.0,True
"Will ARS Pharmaceuticals receive FDA approval for neffy for the treatment of anaphylaxis in children weighing between 33 and 66 pounds by December 31, 2025?",1,1.0,True
"Will the FDA approve Amylyx's AMX-0035 (also known as Albrioza) for the treatment of amyotrophic lateral sclerosis (ALS) by September 29, 2022?",1,1.0,True
"Will Compass Pathways' Phase 3 trial (COMP005) of COMP360 psilocybin therapy for treatment-resistant depression meet its primary endpoint by December 31, 2024?",0,1.0,True
"Will the FDA approve Sanofi's tolebrutinib for the treatment of multiple sclerosis by December 31, 2025?",0,0.9,True
"Will the FDA approve Bristol Myers Squibb's KarXT (xanomeline-trospium) for the treatment of schizophrenia by September 26, 2024?",1,1.0,True
"Will the FDA approve Pfizer's RSV vaccine for older adults by May 31, 2023?",1,1.0,True
"Will Alnylam Pharmaceuticals receive European Commission marketing authorization for Amvuttra (vutrisiran) by October 31, 2022?",1,1.0,True
"Will Takeda and AstraZeneca's MEDI-1341/TAK-341 complete its Phase 2 clinical trial for Multiple System Atrophy by August 31, 2025?",1,0.9,True
"Will the FDA approve LEO Pharma's delgocitinib cream for the treatment of chronic hand eczema (CHE) by December 31, 2025?",1,1.0,True
"Will the FDA approve AbbVie's Skyrizi (risankizumab) for the treatment of ulcerative colitis by June 30, 2024?",1,1.0,True
"Will Amylyx Pharmaceuticals' AMX0035 (Relyvrio) move into Phase 3 clinical trials for the treatment of progressive supranuclear palsy (PSP) by December 31, 2025?",0,1.0,True
"Will the FDA approve MDMA-assisted therapy for the treatment of post-traumatic stress disorder (PTSD) by December 31, 2024?",0,1.0,True
"Will the FDA approve Eli Lilly's tirzepatide for the treatment of moderate-to-severe obstructive sleep apnea by December 31, 2024?",1,1.0,True
"Will CathWorks complete enrollment for the global ALL-RISE clinical study by December 31, 2025?",1,1.0,True
"Will the FDA approve Sanofi and GSK's COVID-19 vaccine for use as a primary series or booster dose by December 31, 2022?",0,1.0,True
"Will the REDUCE-AMI clinical trial (NCT03274700) report meeting its primary composite endpoint of all-cause death or new myocardial infarction by December 31, 2024?",0,1.0,True
"Will the FDA approve pembrolizumab (Keytruda) for the treatment of advanced or recurrent endometrial cancer based on the Phase 3 KEYNOTE-B21 trial results by December 31, 2025?",0,1.0,True
"Will the FDA grant full approval to adagrasib for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer by December 31, 2024?",0,1.0,True
"Will AstraZeneca’s osimertinib (Tagrisso) receive FDA approval for the adjuvant treatment of unresectable Stage III EGFR-mutated non-small cell lung cancer by December 31, 2024?",1,1.0,True
"Will Moleculin Biotech's Phase 2 trial of Annamycin in combination with Ara-C for Acute Myeloid Leukemia (AML) report meeting its primary endpoint by December 31, 2024?",1,0.9,True
"Will the ORION-4 clinical trial of Novartis's inclisiran (Leqvio) meet its primary composite endpoint for cardiovascular outcomes by December 31, 2026?",1,1.0,True
"Will the FDA approve Syndax Pharmaceuticals' revumenib for the treatment of relapsed/refractory KMT2A-rearranged acute leukemia by December 31, 2024?",1,1.0,True
"Will the FDA officially remove oral phenylephrine from the list of nasal decongestants deemed generally recognized as safe and effective (GRASE) by December 31, 2025?",0,1.0,True
"Will Argenx announce that the Phase 2 POTS trial of intravenous Vyvgart (efgartigimod) met its primary endpoint by March 31, 2024?",0,1.0,True
"Will the FDA approve Eli Lilly's donanemab for the treatment of Alzheimer's disease by December 31, 2024?",1,1.0,True
"Will Sanofi enter into an agreement for exclusive global marketing rights for teplizumab (Tzield) with Provention Bio by December 31, 2023?",0,1.0,True
"Will the FDA approve Johnson & Johnson's nipocalimab for the treatment of generalized myasthenia gravis (gMG) by December 31, 2025?",1,1.0,True
"Will AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan (Dato-DXd) receive FDA approval for the treatment of advanced or metastatic non-small cell lung cancer by December 31, 2024?",0,1.0,True
"Will Novo Nordisk receive FDA approval for a new indication for Wegovy (semaglutide) to reduce the risk of major adverse cardiovascular events (MACE) by December 31, 2024?",1,1.0,True
"Will the FDA grant full (traditional) approval for Tivdak (tisotumab vedotin-tftv) for the treatment of recurrent or metastatic cervical cancer by December 31, 2024?",1,1.0,True
"Will Chinook Therapeutics (Novartis) report a successful primary endpoint (reduction in proteinuria) for the Phase 3 ALIGN trial of atrasentan by December 31, 2024?",1,1.0,True
"Will Amylyx Pharmaceuticals formally announce the withdrawal of Relyvrio (AMX0035) from the US market by June 30, 2024?",1,1.0,True
"Will Novo Nordisk's CagriSema Phase 3 trial meet its primary endpoints by March 31, 2025?",1,0.9,True
"Will Coya Therapeutics initiate a Phase 2 clinical trial for COYA 302 in patients with Amyotrophic Lateral Sclerosis (ALS) by December 31, 2024?",0,1.0,True
"Will the FDA approve Amylyx Pharmaceuticals' AMX0035 for the treatment of ALS by September 30, 2022?",1,1.0,True
"Will Bayer's Phase 3 OCEANIC-STROKE trial for asundexian meet its primary efficacy endpoint by December 31, 2024?",0,1.0,True
"Will Levo Therapeutics initiate a new confirmatory clinical study for LV-101 (intranasal carbetocin) in patients with Prader-Willi Syndrome by December 31, 2024?",1,1.0,True
"Will the FDA approve Neurocrine Biosciences' INGREZZA (valbenazine) oral granules sprinkle formulation by April 30, 2024?",1,1.0,True
"Will the FDA approve AstraZeneca's osimertinib (Tagrisso) for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) harboring uncommon EGFR mutations by December 31, 2025?",0,1.0,True
"Will the FDA grant approval for Sanofi and Regeneron's Dupixent (dupilumab) as a treatment for COPD by June 30, 2024?",0,1.0,True
"Will Xeris Biopharma's Recorlev (levoketoconazole) be commercially available for treatment in the United States by March 31, 2022?",1,1.0,True
"Will Eli Lilly's donanemab receive traditional FDA approval for the treatment of Alzheimer's disease by July 31, 2024?",1,1.0,True
"Will Frequency Therapeutics' Phase 2b clinical trial of FX-322 for sensorineural hearing loss (NCT05086276) meet its primary endpoint by June 30, 2023?",0,1.0,True
"Will Bristol Myers Squibb's Augtyro (repotrectinib) receive FDA approval for the treatment of NTRK-positive solid tumors by June 15, 2024?",1,1.0,True
"Will the FDA approve AbbVie's Rinvoq (upadacitinib) for the treatment of Crohn's disease by December 31, 2023?",1,1.0,True
"Will Mayo Clinic initiate a Phase 2 or Phase 3 interventional clinical trial for cavernous angioma with symptomatic hemorrhage (CASH) using quantitative susceptibility mapping (QSM) as a primary endpoint by December 31, 2025?",0,0.9,True
"Will the FDA issue a final administrative order to remove oral phenylephrine from the over-the-counter (OTC) monograph for use as a nasal decongestant by December 31, 2024?",0,1.0,True
"Will Johnson & Johnson's nipocalimab advance to a Phase 3 clinical trial for rheumatoid arthritis by December 31, 2025?",0,1.0,True
"Will Pfizer initiate a Phase 3 clinical trial for ponsegromab in people with cancer and cachexia by December 31, 2025?",1,0.9,True
"Will Merck's investigational monoclonal antibody clesrovimab (MK-1654) receive FDA approval for the prevention of RSV in infants by December 31, 2025?",1,1.0,True
"Will Nanoscope Therapeutics submit a Biologics License Application (BLA) to the FDA for MCO-010 by December 31, 2024?",0,1.0,True
"Will researchers at UC Berkeley or UC Santa Barbara initiate a Phase 2 clinical trial of disulfiram (Antabuse) for the treatment of retinitis pigmentosa by December 31, 2025?",0,0.9,True
"Will Insilico Medicine's Phase 2 clinical trial of the anti-fibrotic small molecule inhibitor INS018_055 complete its primary data collection by December 31, 2025?",1,1.0,True
"Will the FDA approve AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) for the treatment of HER2-low metastatic breast cancer by December 31, 2022?",1,1.0,True
"Will Terns Pharmaceuticals announce the initiation of a Phase 2b clinical trial for TERN-501 in patients with NASH by December 31, 2024?",0,1.0,True
"Will Biogen report that the Phase 3 ENCORE trial of Aduhelm (aducanumab) met its primary endpoint for slowing cognitive decline by December 31, 2024?",0,1.0,True
"Will the FDA approve Janssen's Rybrevant (amivantamab-vmjw) in combination with chemotherapy for the first-line treatment of patients with EGFR Exon 20 insertion-mutated NSCLC by March 31, 2024?",1,1.0,True
"Will the FDA grant full approval to Eli Lilly's donanemab for the treatment of early Alzheimer's disease by December 31, 2024?",1,1.0,True
"Will BioAge complete its Phase 2 clinical trial of BGE-105 for the prevention of muscle loss in patients being treated for obesity by December 31, 2025?",0,1.0,True
"Will Johnson & Johnson's daratumumab-based quadruplet regimen receive FDA approval for transplant-eligible multiple myeloma patients by December 31, 2025?",1,1.0,True
"Will Novo Nordisk's Phase 3 REDEFINE 1 trial for CagriSema in obesity meet its primary endpoint for body weight reduction by December 31, 2024?",1,1.0,True
"Will the FDA approve Sarepta Therapeutics' gene therapy delandistrogene moxeparvovec (SRP-9001) for the treatment of Duchenne muscular dystrophy by June 22, 2023?",1,1.0,True
"Will ABL Bio and Sanofi initiate a Phase 2 clinical trial for ABL301 in patients with Parkinson's disease by December 31, 2025?",0,0.9,True
"Will Azura Ophthalmics' Phase 3 clinical trial for AZR-MD-001 meet its primary endpoints for the treatment of Meibomian Gland Dysfunction (MGD) by December 31, 2025?",0,0.9,True
"Will Takeda Pharmaceuticals' Ninlaro (ixazomib) receive a new FDA label expansion for use in a broader patient population for multiple myeloma by December 31, 2025?",0,0.9,True
"Will Eli Lilly's donanemab receive a positive recommendation from the FDA Advisory Committee for the treatment of early Alzheimer's disease by July 31, 2024?",1,1.0,True
"Will Eli Lilly's SURMOUNT-2 clinical trial for tirzepatide in chronic weight management complete by April 30, 2023?",1,1.0,True
"Will Takeda initiate a Phase 3 trial of TAK-279 in psoriatic arthritis by December 31, 2024?",1,0.9,True
"Will Biogen submit a New Drug Application (NDA) to the FDA for BIIB078 for the treatment of ALS by December 31, 2024?",0,1.0,True
"Will Cybin Inc. receive FDA Breakthrough Therapy Designation for CYB003 in major depressive disorder by December 31, 2024?",1,1.0,True
"Will the FDA approve Syndax Pharmaceuticals' revumenib for the treatment of KMT2A-rearranged acute leukemia by December 31, 2024?",1,1.0,True
"Will Ocular Therapeutix file a New Drug Application (NDA) with the FDA for axpaxli in the treatment of wet age-related macular degeneration by December 31, 2024?",0,1.0,True
"Will Pieris Pharmaceuticals and AstraZeneca announce positive topline results from the Phase 2 clinical trial of PRS-060 for the treatment of asthma by December 31, 2022?",0,1.0,True
"Will Gilead Sciences' magrolimab meet the primary endpoints in its Phase 3 trials for acute myeloid leukemia (AML) by December 31, 2024?",0,1.0,True
"Will Bayer and Merck's Phase 3 VICTOR trial of vericiguat in patients with heart failure with reduced ejection fraction report meeting its primary endpoint by December 31, 2024?",0,1.0,True
"Will Gilead Sciences announce results from the PURPOSE 2 Phase 3 trial of lenacapavir for HIV prevention by March 31, 2025?",0,1.0,True
"Will Nuance Pharma report top-line results from its Phase 2 clinical trial of ensifentrine for the treatment of COPD in China by December 31, 2024?",0,1.0,True
"Will Viking Therapeutics initiate a Phase 2 clinical trial for the oral formulation of VK2735 by December 31, 2024?",1,1.0,True
"Will Alnylam Pharmaceuticals receive FDA approval for vutrisiran (Amvuttra) for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM) by June 30, 2025?",1,1.0,True
"Will Shanghai Henlius Biotech receive marketing authorization for HLX04-O for the treatment of wet age-related macular degeneration (wAMD) from China's National Medical Products Administration (NMPA) by December 31, 2025?",1,1.0,True
"Will Immuneel Therapeutics announce that its Phase 2 IMAGINE trial for CAR-T cell therapy met its primary endpoints by December 31, 2025?",1,0.9,True
"Will BeiGene's zanubrutinib Phase 3 SEQUOIA trial report updated overall survival data for first-line CLL by December 31, 2025?",1,1.0,True
"Will Novo Nordisk apply for FDA approval of semaglutide for the treatment of kidney disease by December 31, 2024?",1,1.0,True
"Will Biogen and Eisai receive full FDA approval for their Alzheimer's treatment Leqembi (lecanemab) by July 31, 2023?",1,1.0,True
"Will Viking Therapeutics initiate a Phase 3 clinical trial for its obesity candidate VK2735 by December 31, 2024?",0,1.0,True
"Will the FDA expand the approved label for Novo Nordisk's Wegovy to include the reduction of major adverse cardiovascular events in adults with established heart disease by December 31, 2024?",1,1.0,True
"Will Minghui Pharmaceutical's MH004 cream meet its primary endpoints in the Phase 3 clinical trial for mild-to-moderate atopic dermatitis by December 31, 2025?",1,1.0,True
"Will Novartis announce that the Phase 1 trial of KAZ954 in combination with NZV930 (NCT04237649) met its primary objectives by December 31, 2025?",0,1.0,True
"Will Gilead Sciences' Bulevirtide receive FDA approval for the treatment of chronic hepatitis delta virus (HDV) by December 31, 2024?",0,1.0,True
"Will the FDA grant full clinical approval to Eisai and Biogen's lecanemab (Leqembi) for the treatment of Alzheimer’s disease by December 31, 2023?",1,1.0,True
"Will Vertex Pharmaceuticals release clinical data from its Phase 1 trial of VX-264 for type 1 diabetes by December 31, 2025?",1,1.0,True
"Will the FDA grant accelerated approval to Kazia Therapeutics' paxalisib for the treatment of newly diagnosed glioblastoma by December 31, 2025?",0,1.0,True
"Will Clene Nanomedicine initiate its Phase 3 clinical trial of CNM-Au8 for the treatment of multiple sclerosis by December 31, 2024?",0,1.0,True
"Will the FDA approve Eli Lilly's lebrikizumab for the treatment of moderate-to-severe atopic dermatitis by December 31, 2024?",1,1.0,True
"Will Summit Therapeutics' bispecific antibody ivonescimab (AK112) receive FDA approval for the treatment of Non-Small Cell Lung Cancer (NSCLC) by December 31, 2025?",0,1.0,True
"Will Insilico Medicine's AI-designed drug candidate for idiopathic pulmonary fibrosis (IPF) successfully complete its Phase 2 clinical trial by December 31, 2025?",1,0.9,True
"Will the FDA approve Amylyx Pharmaceuticals' AMX0035 for the treatment of Amyotrophic Lateral Sclerosis (ALS) by September 30, 2022?",1,1.0,True
"Will Biogen's Alzheimer's drug Aduhelm receive a positive final National Coverage Determination (NCD) for Medicare coverage by June 30, 2022?",0,1.0,True
"Will the FDA approve Pfizer's marstacimab for the treatment of hemophilia A or B by December 31, 2024?",1,1.0,True
"Will the FDA grant de novo clearance or 510(k) clearance for a new Apple Watch AI-enabled diagnostic feature for a condition other than AFib by December 31, 2025?",1,1.0,True
"Will the FDA grant label expansion for GSK's Arexvy RSV vaccine to include adults aged 50-59 by June 30, 2024?",1,1.0,True
"Will the FDA approve Pfizer's RSV vaccine for use in pregnant individuals to protect infants by August 31, 2023?",1,1.0,True
"Will Cybin Inc. begin recruitment for its Phase 3 study of CYB003 for Major Depressive Disorder by March 31, 2024?",0,1.0,True
"Will ACELYRIN initiate the Phase 3 program for lonigutamab in patients with thyroid eye disease by March 31, 2025?",1,1.0,True
"Will Nevro Corporation receive CE Mark or equivalent regulatory approval for its Senza HFX iQ spinal cord stimulation system in Europe by June 30, 2023?",0,1.0,True
"Will the FDA approve Anavex Life Sciences' blarcamesine (Anavex2-73) for the treatment of Rett syndrome by December 31, 2024?",0,1.0,True
"Will Kazia Therapeutics announce FDA consensus on a path to approval for paxalisib in newly diagnosed glioblastoma patients by March 31, 2025?",1,1.0,True
"Will the FDA approve Astellas Pharma's zolbetuximab for the treatment of CLDN18.2-positive gastric or gastroesophageal junction cancer by January 31, 2024?",0,1.0,True
"Will Eli Lilly's obesity drug Zepbound be available for purchase in the United States by December 31, 2023?",1,1.0,True
"Will Jazz Pharmaceuticals' Phase 3 trial of Nabiximols oromucosal spray meet its primary endpoint for the treatment of multiple sclerosis spasticity by June 30, 2022?",0,1.0,True
"Will Eli Lilly's Zepbound (tirzepatide) be available for purchase in the United States by December 31, 2023?",1,1.0,True
"Will the U.S. Supreme Court issue a ruling that maintains the FDA's original 2000 approval of mifepristone by July 1, 2024?",1,1.0,True
"Will AstraZeneca advance the nonalcoholic steatohepatitis (NASH) candidate ION839 (AZD2693) into Phase 3 clinical trials by December 31, 2025?",0,0.9,True
"Will Sage Therapeutics' Zuranolone (Zurzuvae) receive marketing authorization from the European Medicines Agency (EMA) by June 30, 2025?",0,1.0,True
"Will BioXcel Therapeutics submit a New Drug Application (NDA) to the FDA for BXCL501 for the treatment of Alzheimer's-related agitation by December 31, 2024?",0,1.0,True
"Will the FDA approve Eli Lilly's tirzepatide for the treatment of heart failure with preserved ejection fraction (HFpEF) by December 31, 2024?",0,0.9,True
"Will Jazz Pharmaceuticals receive FDA approval for Nabiximols (Sativex) for the treatment of multiple sclerosis-associated spasticity by December 31, 2025?",0,1.0,True
"Will the FDA approve Otsuka and Lundbeck’s supplemental New Drug Application for brexpiprazole (Rexulti) for the treatment of agitation in patients with Alzheimer’s dementia by June 30, 2023?",1,1.0,True
"Will Bristol Myers Squibb's Opdualag (nivolumab and relatlimab-rmbw) receive FDA approval for an expanded indication in pediatric melanoma by December 31, 2025?",0,1.0,True
"Will Eli Lilly's tirzepatide (Zepbound/Mounjaro) receive FDA approval for the treatment of metabolic dysfunction-associated steatohepatitis (MASH/fatty liver disease) by December 31, 2025?",0,0.9,True
"Will Evommune initiate a Phase 2 clinical trial for its IL-18 targeted fusion protein APB-R3 by June 30, 2025?",1,1.0,True
"Will the 'Chinese version of the Zurich claudication questionnaire' validation study for degenerative lumbar spinal stenosis be published in Scientific Reports by May 31, 2025?",1,1.0,True
"Will Bavarian Nordic's Jynneos vaccine receive full FDA approval for use in adolescents aged 12 to 17 by December 31, 2024?",0,1.0,True
"Will top-line results from the Phase 3 clinical trial of exenatide for Parkinson's disease be reported by December 31, 2024?",0,1.0,True
"Will Galapagos initiate clinical trials for at least three CAR-T candidates from the AboundBio library by June 30, 2025?",1,1.0,True
"Will Biogen and Eisai receive full FDA approval for their Alzheimer's treatment Leqembi (lecanemab) by July 31, 2023?",1,1.0,True
"Will the FDA approve Applied Therapeutics' drug govorestat (AT-007) for the treatment of classic galactosemia by November 28, 2024?",0,1.0,True
"Will Johnson & Johnson’s Shockwave Medical unit begin the limited market release of the Javelin peripheral intravascular lithotripsy (IVL) catheter by March 31, 2025?",1,1.0,True
"Will Edesa Biotech's Phase 2 BARDA-funded platform trial for paridiprubart in general ARDS meet its primary endpoint by December 31, 2025?",0,1.0,True
"Will Johnson & Johnson's MARIPOSA trial (NCT04487080) demonstrate a statistically significant improvement in overall survival for the amivantamab and lazertinib arm compared to the osimertinib arm by December 31, 2025?",1,1.0,True
"Will AstraZeneca's Phase 3 ADRIATIC trial for Imfinzi (durvalumab) meet its primary endpoint of overall survival in limited-stage small-cell lung cancer by December 31, 2024?",1,1.0,True
"Will Astellas Pharma and Seagen's EV-302 trial results for Padcev and Keytruda lead to a European Commission marketing authorization for first-line advanced urothelial carcinoma by August 31, 2024?",1,1.0,True
"Will Aldeyra Therapeutics' reproxalap receive FDA approval for the treatment of dry eye disease by December 31, 2024?",0,1.0,True
"Will Topas Therapeutics announce the commencement of a Phase 2b or Phase 3 clinical trial for TPM502 in celiac disease by December 31, 2025?",1,0.9,True
"Will MoonLake Immunotherapeutics initiate a Phase 3 clinical trial of sonelokimab for the treatment of psoriatic arthritis by December 31, 2024?",1,1.0,True
"Will Moderna's combination flu and COVID-19 vaccine, mRNA-1083, receive FDA approval by December 31, 2025?",0,1.0,True
"Will Heartseed's lead candidate HS-001 complete its Phase 1/2 clinical trial for heart failure by December 31, 2025?",0,0.9,True
"Will the FDA approve UCB's zilucoplan for the treatment of generalized myasthenia gravis (gMG) by December 31, 2023?",1,1.0,True
"Will Futura Medical's MED3000 (Eroxon) be commercially available over-the-counter in United States retail pharmacies by June 30, 2024?",0,1.0,True
"Will AstraZeneca’s nirsevimab (Beyfortus) be commercially available in the U.S. for the 2023-2024 RSV season by October 31, 2023?",1,0.9,True
"Will Sanofi and GSK's next-generation beta COVID-19 vaccine receive European Commission approval by December 31, 2022?",1,1.0,True
"Will GENFIT announce topline data from its Phase 3 ELATIVE trial for elafibranor in Primary Biliary Cholangitis by June 30, 2023?",1,1.0,True
"Will Regeneron initiate a Phase 2 trial combining trevogrumab and garetosmab with incretin-based treatments for obesity by September 30, 2024?",1,1.0,True
"Will ImCheck Therapeutics initiate a pivotal clinical trial for ICT01 by December 31, 2025?",0,1.0,True
"Will NeuroSense report neurofilament results from its Phase IIb PARADIGM trial of PrimeC for ALS by March 31, 2024?",0,1.0,True
"Will Organon and Samsung Bioepis launch the high-concentration formulation of the Hadlima biosimilar in the United States by July 31, 2023?",1,1.0,True
"Will Creative Medical Technology Holdings announce top-line results from its Phase 1/2 clinical trial of CELZ-201 for Type 1 diabetes by December 31, 2025?",0,0.9,True
"Will the FDA approve Journey Medical Corporation's DFD-29 for the treatment of papulopustular rosacea by December 31, 2024?",1,1.0,True
"Will the FDA approve Alnylam Pharmaceuticals' patisiran for the treatment of ATTR amyloidosis with cardiomyopathy by October 31, 2023?",0,1.0,True
"Will AstraZeneca's Phase 3 trial for Dato-DXd (TROPION-Lung01) receive FDA approval for second-line non-small cell lung cancer by December 31, 2024?",0,1.0,True
"Will Novo Nordisk's REDEFINE 1 Phase 3 trial for CagriSema meet its primary endpoint of superior weight loss compared to semaglutide by December 31, 2024?",1,1.0,True
"Will the FDA approve UCB's zilucoplan for the treatment of adult patients with acetylcholine receptor autoantibody-positive generalized myasthenia gravis by December 31, 2023?",1,1.0,True
"Will the FDA officially restrict the use of checkpoint inhibitors for PD-L1 negative esophageal cancer patients, in line with the ODAC recommendation, by December 31, 2024?",0,1.0,True
"Will Maze Therapeutics initiate a Phase 2 trial of MZE829 for APOL1 kidney disease by March 31, 2025?",1,1.0,True
"Will AstraZeneca’s Phase 3 datopotamab deruxtecan (Dato-DXd) receive FDA approval for the treatment of non-small cell lung cancer by December 31, 2024?",0,1.0,True
"Will the FDA approve Madrigal Pharmaceuticals' resmetirom (Rezdiffra) for the treatment of NASH by June 30, 2024?",1,1.0,True
"Will Eliem Therapeutics announce an agreement for a merger or acquisition with another company by June 30, 2024?",1,1.0,True
"Will the Phase 3 DESTINY-Breast05 trial (NCT04622319) meet its primary endpoint of invasive disease-free survival by December 31, 2025?",1,1.0,True
"Will the FDA approve Bristol Myers Squibb's KarXT (xanomeline-trospium) for the treatment of schizophrenia by September 26, 2024?",1,1.0,True
"Will Tonix Pharmaceuticals report successful results from its Phase 3 trial of TNX-102 SL for fibromyalgia by December 31, 2023?",1,1.0,True
"Will Fortress Biotech and Journey Medical announce positive top-line results from their Phase 3 clinical trials of DFD-29 for the treatment of papulopustular rosacea by June 30, 2023?",0,1.0,True
"Will BrainStorm Cell Therapeutics receive FDA approval for NurOwn by December 31, 2023?",0,1.0,True
"Will the FDA approve Compass Pathways' psilocybin treatment (COMP360) for severe depression by December 31, 2026?",0,1.0,True
"Will the FDA approve Regeneron's odronextamab for the treatment of relapsed or refractory follicular lymphoma by June 30, 2025?",0,1.0,True
"Will Genentech's venetoclax receive FDA approval for the treatment of relapsed or refractory multiple myeloma by December 31, 2025?",0,1.0,True
"Will the FDA grant approval to Eli Lilly's lebrikizumab for the treatment of moderate-to-severe atopic dermatitis by December 31, 2024?",1,1.0,True
"Will the FDA approve BioXcel Therapeutics' BXCL501 for the treatment of agitation associated with Alzheimer's disease by December 31, 2025?",0,1.0,True
"Will the FDA approve Moderna's respiratory syncytial virus (RSV) vaccine by April 30, 2024?",0,1.0,True
"Will YS Biopharma announce that its PIKA rabies vaccine Phase 3 trial met its primary immunogenicity endpoints by December 31, 2025?",1,1.0,True
"Will Takeda Pharmaceuticals' Takhzyro (lanadelumab-flyo) receive European Commission approval for use in children aged 2 to 11 with hereditary angioedema by December 31, 2023?",1,1.0,True
"Will CG Oncology report topline data from its Phase 3 trial of cretostimogene grenadenorepvec for non-muscle invasive bladder cancer by December 31, 2024?",1,1.0,True
"Will Abivax's lead candidate Phase 3 clinical trial for the treatment of ulcerative colitis meet its primary endpoints by December 31, 2025?",1,1.0,True
"Will Vielight Inc. publish or announce clinical results for its U.S. study of brain stimulation photobiomodulation (PBM) for long COVID-19 cognitive impairment by December 31, 2025?",1,0.9,True
"Will Novo Nordisk's REDEFINE-1 Phase 3 trial for CagriSema meet its primary endpoint for body weight reduction by December 31, 2024?",1,1.0,True
"Will Merck's Phase 3 KEYNOTE-A18 trial evaluating pembrolizumab meet its primary endpoint in patients with newly diagnosed high-risk locally advanced cervical cancer by December 31, 2024?",1,1.0,True
"Will the FDA approve Exelixis' Cabometyx (cabozantinib) for the treatment of advanced neuroendocrine tumors by December 31, 2024?",0,1.0,True
"Will Eisai and Biogen's Leqembi (lecanemab) receive traditional FDA approval for the treatment of Alzheimer’s disease by July 31, 2023?",1,1.0,True
"Will Amylyx Pharmaceuticals' AMX0035 (Relyvrio) move into Phase 3 clinical trials for the treatment of progressive supranuclear palsy (PSP) by December 31, 2025?",0,1.0,True
"Will the U.S. Supreme Court issue a ruling in U.S. Food and Drug Administration v. Alliance for Hippocratic Medicine that restricts the existing FDA-approved access to mifepristone by June 30, 2024?",0,1.0,True
"Will Genexine Co. Ltd. file a Biologics License Application (BLA) for eftansomatropin alfa (GX-H9/TJ-101) in China by December 31, 2024?",1,1.0,True
"Will Viking Therapeutics initiate a Phase 3 clinical trial for its obesity drug VK2735 by December 31, 2024?",0,1.0,True
"Will the European Commission grant marketing authorization for AstraZeneca and Daiichi Sankyo’s Enhertu for the treatment of HER2-positive advanced gastric cancer by March 31, 2023?",1,1.0,True
"Will Sarepta Therapeutics' Elevidys receive full FDA approval for the treatment of Duchenne muscular dystrophy by August 31, 2024?",1,1.0,True
"Will the FDA approve Takeda's Takhzyro (lanadelumab) for the prevention of hereditary angioedema (HAE) attacks in children aged 2 to <12 years by December 31, 2023?",1,1.0,True
"Will the FDA approve Eli Lilly's tirzepatide for the treatment of obstructive sleep apnea in adults with obesity by December 31, 2024?",1,1.0,True
"Will Eli Lilly receive FDA approval for Verzenio (abemaciclib) in combination with fulvestrant for patients with HR+/HER2- advanced breast cancer following progression on a CDK4/6 inhibitor based on the postMONARCH trial results by June 30, 2025?",0,1.0,True
"Will the FDA grant supplemental Biologics License Application (sBLA) approval for Enhertu (trastuzumab deruxtecan) for patients with previously treated unresectable or metastatic HER2-low or HER2-ultralow breast cancer by December 31, 2024?",0,1.0,True
"Will the FDA grant approval to Sanofi and AstraZeneca's nirsevimab for the prevention of RSV in infants by August 31, 2023?",1,1.0,True
"Will Roche announce that the tominersen Phase 2 GENERATION HD2 study met its primary safety and efficacy endpoints by June 30, 2025?",0,1.0,True
"Will AstraZeneca's Phase 3 datopotamab deruxtecan (Dato-DXd) receive FDA approval for the treatment of non-small cell lung cancer by December 31, 2024?",0,1.0,True
"Will Johnson & Johnson's nipocalimab receive FDA approval for the treatment of generalized myasthenia gravis (gMG) by December 31, 2025?",1,1.0,True
"Will Vanda Pharmaceuticals receive FDA approval for Fanapt (iloperidone) in the treatment of bipolar I disorder by April 30, 2024?",1,1.0,True
"Will Wave Life Sciences' Phase 1b/2a RestorAATion-2 trial for WVE-006 in Alpha-1 antitrypsin deficiency meet its primary endpoint for safety and protein expression by December 31, 2024?",1,0.9,True
"Will LEO Pharma's Anzupgo (delgocitinib) cream meet its primary endpoints in its Phase 3 trial for lichen sclerosus by December 31, 2025?",0,1.0,True
"Will Axsome Therapeutics receive FDA approval for AXS-12 for the treatment of narcolepsy by December 31, 2025?",0,1.0,True
"Will Fidson Healthcare PLC announce the commencement of any Phase 2 or Phase 3 clinical trial for a new proprietary drug candidate by December 31, 2025?",0,0.9,True
"Will the FDA approve Amgen's UPLIZNA (inebilizumab-cdon) for the treatment of IgG4-related disease (IgG4-RD) by December 31, 2025?",1,1.0,True
"Will Gilead Sciences present new HIV treatment or prevention clinical data at the Conference on Retroviruses and Opportunistic Infections (CROI) by March 1, 2026?",1,1.0,True
"Will the U.S. Court of Appeals for the 5th Circuit uphold the FDA's 2000 approval of Danco Laboratories' mifepristone in its final ruling following the May 17, 2023 arguments?",1,1.0,True
"Will Novo Nordisk's Phase 3 REDEFINE-1 trial for CagriSema meet its primary endpoint of percentage change in body weight by December 31, 2024?",1,1.0,True
"Will Curio Digital Therapeutics' MamaLift Plus receive FDA clearance or approval for the treatment of postpartum depression by December 31, 2026?",1,1.0,True
"Will Amylyx Pharmaceuticals officially withdraw Relyvrio from the US market by June 30, 2024?",1,1.0,True
"Will Imbria Pharmaceuticals initiate a Phase 3 clinical trial for ninerafaxstat in patients with chronic stable angina by December 31, 2025?",0,0.9,True
"Will the Phase 3 IsKia (EMN24) trial report results for sustained 12-month MRD negativity for the Isa-KRd arm by December 31, 2025?",1,1.0,True
"Will LivaNova publish the final data from the RECOVER Clinical Study unipolar patient cohort in a peer-reviewed journal by December 31, 2024?",1,1.0,True
"Will the FDA grant approval for Eli Lilly's tirzepatide (Zepbound) for a weight-related indication in pediatric patients by December 31, 2025?",0,1.0,True
"Will Elanco's SGLT2 inhibitor velagliflozin (Senvelgo) receive FDA approval for the treatment of diabetes mellitus in cats by December 31, 2023?",1,1.0,True
"Will Rapt Therapeutics release interim data from its Phase 2b clinical trial of zelnecirnon in atopic dermatitis by December 31, 2024?",0,1.0,True
"Will NeuroSense Therapeutics initiate its Phase 3 clinical study of PrimeC for the treatment of ALS by June 30, 2025?",0,1.0,True
"Will Bharat Biotech's intranasal COVID-19 vaccine (BBV154) receive Emergency Use Authorization from the DCGI for use in India by December 31, 2022?",1,1.0,True
"Will the FDA grant full approval to Genmab and Seagen's TIVDAK for recurrent or metastatic cervical cancer by December 31, 2024?",1,1.0,True
"Will Viridian Therapeutics announce topline results from the THRIVE Phase 3 trial of VRDN-001 by June 30, 2024?",0,0.9,True
"Will the FDA lift the clinical hold on the Phase 2b/3 RHAPSODY-2 trial of the drug 3K3A-APC for ischemic stroke by December 31, 2024?",1,1.0,True
"Will Eli Lilly's Phase 3 TRAILBLAZER-ALZ 2 trial for donanemab meet its primary endpoint by June 30, 2023?",1,1.0,True
"Will Bristol Myers Squibb (Karuna Therapeutics) receive FDA approval for KarXT (xanomeline-trospium) for the treatment of schizophrenia by September 30, 2024?",1,1.0,True
"Will Simcere Pharmaceutical submit a New Drug Application (NDA) for rademikibart for the treatment of eczema in Greater China by March 31, 2024?",0,1.0,True
"Will the BHF PROTECT-TAVI trial of the Sentinel Cerebral Protection System meet its primary endpoint of reducing stroke within 72 hours of TAVR by December 31, 2026?",0,1.0,True
"Will the FDA approve UCB Pharma's psoriasis drug bimekizumab by June 30, 2023?",0,0.9,True
"Will the FDA approve AstraZeneca and Merck's sNDA for Lynparza (olaparib) for use in patients with metastatic castration-resistant prostate cancer by June 30, 2024?",1,1.0,True
"Will the FDA approve Vertex Pharmaceuticals' suzetrigine (VX-548) for the treatment of acute pain by January 30, 2025?",1,1.0,True
"Will Viatris and Kindeva Drug Delivery commercially launch Breyna, the generic version of Symbicort, in the United States by December 31, 2022?",0,1.0,True
"Will Novocure receive FDA approval for its treatment for locally advanced pancreatic cancer by December 31, 2026?",1,1.0,True
"Will the National Institute for Health and Care Excellence (NICE) recommend the combination of amivantamab and lazertinib for use in the NHS for EGFR-mutated advanced non-small cell lung cancer by December 31, 2025?",1,1.0,True
"Will the FDA approve Eli Lilly's lebrikizumab for the treatment of moderate-to-severe atopic dermatitis by December 31, 2024?",1,1.0,True
"Will Iveric Bio's Phase 3 GATHER2 trial of avacincaptad pegol (Zimura) meet its primary endpoint of reducing the rate of geographic atrophy growth by September 30, 2022?",1,1.0,True
"Will Bristol Myers Squibb's CheckMate 9DW Phase 3 trial (NCT04039607) reach its official study completion by September 30, 2026?",1,0.9,True
"Will Minoryx Therapeutics and Neuraxpharm submit a Marketing Authorization Application (MAA) for leriglitazone to the European Medicines Agency (EMA) by June 30, 2025?",0,1.0,True
"Will the FDA grant De Novo marketing authorization or 510(k) clearance for at least one generative AI-based clinical diagnostic software application by December 31, 2025?",0,0.9,True
"Will Novo Nordisk's Phase 3 ESSENCE trial for semaglutide in patients with non-alcoholic steatohepatitis (NASH) meet its primary endpoint by December 31, 2024?",1,1.0,True
"Will Amylyx Pharmaceuticals officially announce the withdrawal of Relyvrio (AMX0035) from the U.S. market by June 30, 2024, following the results of the Phase 3 PHOENIX trial?",1,1.0,True
"Will Biomea Fusion announce that its BMF-219 Phase 2 trial for Type 2 Diabetes (COVALENT-111) met its primary endpoint by December 31, 2024?",1,1.0,True
"Will the FDA approve TG Therapeutics' ublituximab for the treatment of relapsing forms of multiple sclerosis by September 28, 2022?",0,1.0,True
"Will LEO Pharma's delgocitinib receive FDA approval for the treatment of chronic hand eczema by December 31, 2024?",0,1.0,True
"Will Eli Lilly announce topline results for the tirzepatide Phase 3 SURMOUNT-2 clinical trial by December 31, 2023?",1,1.0,True
"Will Moderna's mRNA-1345 RSV vaccine receive FDA approval for the prevention of respiratory syncytial virus-associated lower respiratory tract disease in adults aged 60 years or older by June 30, 2024?",1,1.0,True
"Will Accord BioPharma commercially launch its Stelara biosimilar, Imuldosa (ustekinumab-srlf), in the United States by March 31, 2025?",0,1.0,True
"Will the European Medicines Agency (EMA) approve Sanofi and Regeneron's Dupixent (dupilumab) for the treatment of children aged 6 months to 5 years with atopic dermatitis by June 30, 2023?",1,1.0,True
"Will the FDA approve AstraZeneca and Amgen's TEZSPIRE (tezepelumab) for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) by December 31, 2025?",1,1.0,True
"Will the FDA publish the FY 2024 OMUFA facility fee rates for Monograph Drug Facilities (MDF) and Contract Manufacturing Organizations (CMO) by March 31, 2024?",1,1.0,True
"Will AstraZeneca's Phase 3 datopotamab deruxtecan (Dato-DXd) trial for non-small cell lung cancer meet its primary endpoints by December 31, 2024?",0,1.0,True
"Will the FDA approve Roche's tiragolumab for the treatment of esophageal squamous cell carcinoma (ESCC) by December 31, 2025?",0,1.0,True
"Will Amgen's sotorasib (Lumakras) receive full FDA approval for the treatment of KRAS G12C-mutated non-small cell lung cancer by June 30, 2024?",0,1.0,True
"Will Tonix Pharmaceuticals announce the initiation of a Phase 3 trial for TNX-102 SL in fibromyalgia-type long Covid by December 31, 2024?",0,1.0,True
"Will Bharat Biotech's Covaxin (BBV152) receive full FDA approval for use in adults in the United States by December 31, 2025?",0,1.0,True
"Will Jazz Pharmaceuticals receive regulatory approval for Epidiolex in Japan by December 31, 2025?",0,1.0,True
Will the InTandem neurorehabilitation system (NCT04121754) meet its primary endpoint of a significant increase in walking speed compared to active control by February 2024?,1,1.0,True
"Will Anthos Therapeutics report that its Phase 3 trial of abelacimab for the treatment of atrial fibrillation met its primary endpoints by December 31, 2025?",0,1.0,True
"Will Kelun-Biotech's SKB-264 (sacituzumab tirumotecan) meet its primary endpoint of progression-free survival (PFS) in the Phase 3 trial for metastatic triple-negative breast cancer by December 31, 2024?",0,0.95,True
"Will the FDA approve Casgevy (exagamglogene autotemcel) for the treatment of transfusion-dependent beta-thalassemia by March 30, 2024?",1,1.0,True
"Will Eli Lilly's Phase 3 TRAILBLAZER-ALZ 2 extension study for donanemab meet its primary endpoint by June 30, 2025?",1,0.9,True
"Will INOVIO Pharmaceuticals receive FDA approval for its experimental vaccine INO-3107 for the treatment of recurrent respiratory papillomatosis by December 31, 2025?",0,1.0,True
"Will Jazz Pharmaceuticals report that its Phase II trial of suvecaltamide in Parkinson's disease tremor (NCT05642442) met its primary endpoint by March 31, 2025?",0,0.9,True
"Will Amgen release the full results from its Phase 2 clinical trial of MariTide for obesity by December 31, 2024?",0,1.0,True
"Will the FDA approve Eli Lilly's tirzepatide for chronic weight management in adults without diabetes by December 31, 2023?",1,1.0,True
"Will ZZ Biotech and the Keck School of Medicine of USC begin enrollment for the Phase 3 trial of 3K3A-APC in acute ischemic stroke by December 31, 2025?",1,0.9,True
"Will the porcelain-derived cell therapy OPF-310 complete its current Phase 1 clinical trial for type 1 diabetes by December 31, 2026?",0,1.0,True
"Will Rocket Pharmaceuticals receive FDA approval for its KAND-101 (RP-A501) gene therapy for Danon disease by June 30, 2025?",0,1.0,True
"Will the FDA approve Anavex Life Sciences' blarcamesine (Anavex2-73) for the treatment of Rett syndrome by December 31, 2024?",0,1.0,True
"Will the FDA approve Eli Lilly's tirzepatide for chronic weight management in adults with obesity or overweight by December 31, 2023?",1,1.0,True
"Will Yakumi Plus Effervescent tablets receive FDA approval for the treatment of gastrointestinal diseases by December 31, 2025?",0,1.0,True
"Will BridgeBio Pharma receive FDA approval for acoramidis for the treatment of ATTR-CM by its PDUFA date of November 29, 2024?",1,1.0,True
"Will Boehringer Ingelheim's Phase 3 trial for neridamrev (BI 1015550) in patients with Idiopathic Pulmonary Fibrosis (IPF) meet its primary endpoint of forced vital capacity change by December 31, 2025?",1,1.0,True
"Will the FDA approve Eli Lilly's tirzepatide for the treatment of moderate-to-severe obstructive sleep apnea by December 31, 2024?",1,1.0,True
"Will Visus Therapeutics announce results for its phase 3 BRIO-II trial of Brimochol PF for presbyopia by December 31, 2024?",0,1.0,True
"Will AstraZeneca and Daiichi Sankyo's datopotamab deruxtecan (Dato-DXd) receive FDA approval for the treatment of advanced or metastatic non-small cell lung cancer by December 31, 2024?",0,1.0,True
"Will Vertex Pharmaceuticals receive FDA approval for a new triple-combination CFTR modulator therapy for cystic fibrosis by December 31, 2025?",1,1.0,True
"Will Eli Lilly's orforglipron (LY3502970) meet its primary endpoint in the Phase 3 ATTAIN-1 clinical trial for chronic weight management by December 31, 2025?",1,1.0,True
"Will Biogen's litifilimab (BIIB059) meet the primary endpoint in the Phase 3 TOPAZ-1 trial for systemic lupus erythematosus by December 31, 2025?",0,1.0,True
"Will MorphoSys submit a New Drug Application (NDA) to the FDA for pelabresib in myelofibrosis by June 30, 2024?",1,0.9,True
"Will the FDA approve AbbVie's navitoclax for the treatment of myelofibrosis by December 31, 2025?",0,0.9,True
"Will the FDA formally adopt Minimal Residual Disease (MRD) as an endpoint for accelerated approval in multiple myeloma trials by December 31, 2024?",0,1.0,True
"Will the FDA grant full (traditional) approval to Sarepta Therapeutics' gene therapy SRP-9001 (Elevidys) for Duchenne muscular dystrophy by August 31, 2024?",1,1.0,True
"Will GSK announce that its Phase 3 trial for a new MenABCWY vaccine candidate has successfully met all its primary endpoints by December 31, 2024?",1,1.0,True
"Will Italfarmaco's Duvyzat (givinostat) receive FDA approval for the treatment of Duchenne muscular dystrophy (DMD) by March 31, 2024?",1,1.0,True
"Will the FDA approve Travere Therapeutics' sparsentan for the treatment of focal segmental glomerulosclerosis (FSGS) by December 31, 2024?",0,1.0,True
Will University Clinic Golnik's pragmatic trial (NCT06207500) show a significant reduction in unplanned healthcare utilization within 30 days of discharge for the pharmacist-led medication reconciliation group compared to standard care?,0,1.0,True
"Will Cytokinetics initiate its Phase 3 clinical trial of aficamten in patients with non-obstructive hypertrophic cardiomyopathy (nHCM) by December 31, 2023?",0,1.0,True
"Will the FDA approve Karuna Therapeutics' KarXT (xanomeline-trospium) for the treatment of schizophrenia in adults by September 26, 2024?",1,1.0,True
"Will the US Supreme Court uphold the 5th Circuit Court of Appeals decision to restrict the FDA's 2016 and 2021 expansions of mifepristone by December 31, 2024?",0,1.0,True
"Will the FDA grant De Novo marketing authorization to Apple for its 'Hearing Aid Feature' on AirPods Pro 2 by October 31, 2024?",1,1.0,True
"Will the FDA approve Karuna Therapeutics' KarXT (xanomeline-trospium) for the treatment of schizophrenia by September 26, 2024?",1,1.0,True
"Will ARS Pharmaceuticals receive European Commission marketing authorization for Neffy (epinephrine nasal spray) for the treatment of allergic reactions (anaphylaxis) by December 31, 2024?",1,1.0,True
"Will Destiny Pharma announce the commencement of a Phase 3 clinical trial for its XF-73 nasal gel by December 31, 2024?",0,1.0,True
"Will the FDA approve SpringWorks Therapeutics' nirogacestat for the treatment of adult patients with progressing desmoid tumors by November 30, 2023?",1,1.0,True
"Will the FDA approve Lykos Therapeutics' MDMA-assisted therapy for the treatment of post-traumatic stress disorder (PTSD) by August 11, 2024?",0,1.0,True
"Will Travere Therapeutics announce topline data from the confirmatory eGFR endpoint analysis of the Phase III PROTECT trial for Filspari by December 31, 2023?",1,1.0,True
"Will the FDA approve Eli Lilly's tirzepatide for chronic weight management in adults without type 2 diabetes by December 31, 2023?",1,1.0,True
"Will the Phase 1b trial of ricolinostat (ACY-1215) for relapsed or refractory multiple myeloma meet its primary endpoints by December 31, 2025?",1,1.0,True
"Will Roche's Phase 3 SKYSCRAPER-01 trial of tiragolumab in non-small cell lung cancer meet its primary endpoint of overall survival by December 31, 2024?",0,1.0,True
"Will Eli Lilly's donanemab receive FDA approval for the treatment of early symptomatic Alzheimer's disease by July 31, 2024?",1,1.0,True
"Will the FDA approve Karuna Therapeutics' KarXT for the treatment of schizophrenia in adults by September 26, 2024?",1,1.0,True
"Will Eli Lilly's Phase 3 TRAILBLAZER-ALZ 3 study of donanemab for preclinical Alzheimer's disease meet its primary endpoint of clinical progression improvement by December 31, 2024?",0,1.0,True
"Will Inari Medical announce that the PEERLESS randomized controlled trial met its primary endpoint by December 31, 2024?",1,1.0,True
"Will Agios Pharmaceuticals' Pyrukynd (mitapivat) receive FDA approval for the treatment of thalassemia by December 31, 2025?",1,1.0,True
"Will the European Medicines Agency (EMA) approve Italfarmaco's Duvyzat (givinostat) for the treatment of Duchenne muscular dystrophy by June 30, 2025?",1,1.0,True
"Will the FDA maintain the current Risk Evaluation and Mitigation Strategy (REMS) for Danco Laboratories' Mifeprex (mifepristone) without reinstating pre-2016 in-person dispensing requirements through December 31, 2024?",1,1.0,True
"Will Acrivon Therapeutics report positive Phase 2 clinical trial results for ACR-368 in patients with platinum-resistant ovarian cancer by December 31, 2024?",1,1.0,True
"Will the FDA issue updated formal guidance on the implementation of precision dosing in Phase 3 clinical trials by December 31, 2025?",1,0.9,True
Did SynAct Pharma's EXPAND Phase 2b trial of resomelagon (AP1189) meet its primary endpoint of significant ACR20 improvement at 12 weeks?,0,1.0,True
"Will the FDA approve Alvotech and Teva's SELARSDI (ustekinumab-aekn) as an interchangeable biosimilar to Stelara by April 30, 2025?",1,1.0,True
"Will Poolbeg Pharma initiate a Phase 2 clinical trial for POLB 001 in cancer immunotherapy-induced cytokine release syndrome by December 31, 2025?",0,0.9,True
"Will AMO Pharma receive FDA approval for AMO-02 (tideglusib) for the treatment of congenital myotonic dystrophy type 1 by December 31, 2025?",0,1.0,True
"Will Marinus Pharmaceuticals receive FDA approval for intravenous (IV) ganaxolone for the treatment of refractory status epilepticus (RSE) by June 30, 2025?",0,1.0,True
"Will Dr. Joe Delaney or MUSC Hollings Cancer Center initiate a Phase 1 or Phase 2 clinical trial testing hydroxychloroquine in combination with a metabolism or division-pathway inhibitor for colorectal or ovarian cancer by December 31, 2025?",1,1.0,True
"Will Sanofi's Phase 2 clinical trial of SAR443820 in multiple sclerosis reach its primary completion date by September 30, 2025?",1,1.0,True
"Will Anavex Life Sciences receive FDA approval for blarcamesine (ANAVEX 2-73) for the treatment of Alzheimer's disease by December 31, 2025?",0,1.0,True
"Will Pfizer's maternal RSV vaccine receive FDA approval for the protection of infants by August 31, 2023?",1,1.0,True
"Will Merck & Co. initiate its Phase 3 clinical trial for the V116 pneumococcal vaccine by July 31, 2022?",1,1.0,True
"Will Arcutis Biotherapeutics receive FDA approval for Roflumilast (ZORYVE) cream 0.15% for the treatment of atopic dermatitis in children ages 6 years and older by July 31, 2024?",1,1.0,True
"Will Viking Therapeutics initiate a Phase 3 clinical trial for the oral formulation of VK2735 by December 31, 2025?",0,1.0,True
"Will Viking Therapeutics' Phase 3 trial for VK2809 in patients with biopsy-confirmed NASH meet its primary endpoint by June 30, 2025?",0,1.0,True
"Will the FDA grant traditional (full) approval to Eisai and Biogen's Leqembi (lecanemab) for the treatment of Alzheimer’s disease by July 31, 2023?",1,1.0,True
"Will Zosano Pharma receive FDA approval for its M207 (Qtrypta) migraine patch by December 31, 2023?",0,1.0,True
